Title,Authors,Platform,Cited_url,Cited_count,Year
Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes,"R Hovorka, V Canonico, LJ Chassin, U Haueter, M Massi-Benedetti, ...","Physiological measurement 25 (4), 905",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2218445616383204332,1114,2004
Continuous glucose monitoring and closed‐loop systems,R Hovorka,"Diabetic medicine 23 (1), 1-12",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16081127018834525623,465,2006
Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial,"R Hovorka, JM Allen, D Elleri, LJ Chassin, J Harris, D Xing, C Kollman, ...","The Lancet 375 (9716), 743-751",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18049811680027672184,456,2010
"Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT","R Hovorka, F Shojaee-Moradie, PV Carroll, LJ Chassin, IJ Gowrie, ...","American Journal of Physiology-Endocrinology and Metabolism 282 (5), E992-E1007",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13371703160412723567,378,2002
International consensus on use of continuous glucose monitoring,"T Danne, R Nimri, T Battelino, RM Bergenstal, KL Close, JH DeVries, ...","Diabetes care 40 (12), 1631-1640",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2691196486996064762,359,2017
Home use of an artificial beta cell in type 1 diabetes,"H Thabit, M Tauschmann, JM Allen, L Leelarathna, S Hartnell, ...","New England Journal of Medicine 373 (22), 2129-2140",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=308754019592979936,304,2015
Closed-loop insulin delivery: from bench to clinical practice,R Hovorka,"Nature Reviews Endocrinology 7 (7), 385",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14478206932774073776,250,2011
Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies,"R Hovorka, K Kumareswaran, J Harris, JM Allen, D Elleri, D Xing, ...","Bmj 342, d1855",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9813239636960452612,249,2011
"Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive …","J Plank, J Blaha, J Cordingley, ME Wilinska, LJ Chassin, C Morgan, ...","Diabetes care 29 (2), 271-276",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2176824705341414610,226,2006
Insulin kinetics in type-1 diabetes: continuous and bolus delivery of rapid acting insulin,"ME Wilinska, LJ Chassin, HC Schaller, L Schaupp, TR Pieber, R Hovorka","IEEE Transactions on Biomedical Engineering 52 (1), 3-12",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3519691413250048749,224,2004
"Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial","R Hovorka, D Elleri, H Thabit, JM Allen, L Leelarathna, R El-Khairi, ...","Diabetes care 37 (5), 1204-1211",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11602906041066772919,191,2014
Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes,"ME Wilinska, LJ Chassin, CL Acerini, JM Allen, DB Dunger, R Hovorka","Journal of diabetes science and technology 4 (1), 132-144",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10084801122705563489,184,2010
A probabilistic approach to glucose prediction and insulin dose adjustment: description of metabolic model and pilot evaluation study,"S Andreassen, JJ Benn, R Hovorka, KG Olesen, ER Carson","Computer methods and programs in biomedicine 41 (3-4), 153-165",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=173983998031927859,168,1994
Clinical review: consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults,"S Finfer, J Wernerman, JC Preiser, T Cass, T Desaive, R Hovorka, ...","Critical Care 17 (3), 229",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14654879260512939837,160,2013
Closing the loop: the adicol experience,"R Hovorka, LJ Chassin, ME Wilinska, V Canonico, JA Akwi, MO Federici, ...","Diabetes technology & therapeutics 6 (3), 307-318",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9361777131831411584,159,2004
"Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study","H Thabit, A Lubina-Solomon, M Stadler, L Leelarathna, E Walkinshaw, ...","The Lancet Diabetes & Endocrinology 2 (9), 701-709",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17100560947809921560,146,2014
ISEC: a program to calculate insulin secretion,"R Hovorka, PA Soons, MA Young","Computer methods and programs in biomedicine 50 (3), 253-264",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14113348768326975751,144,1996
Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial,"D Elleri, JM Allen, K Kumareswaran, L Leelarathna, M Nodale, K Caldwell, ...","Diabetes care 36 (4), 838-844",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14829258858208882629,137,2013
Outcome measures for artificial pancreas clinical trials: a consensus report,"DM Maahs, BA Buckingham, JR Castle, A Cinar, ER Damiano, E Dassau, ...","Diabetes Care 39 (7), 1175-1179",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12137840004552623072,124,2016
Coming of age: the artificial pancreas for type 1 diabetes,"H Thabit, R Hovorka","Diabetologia 59 (9), 1795-1805",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3688628314587575443,123,2016
Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes,"HR Murphy, D Elleri, JM Allen, J Harris, D Simmons, G Rayman, ...","Diabetes care 34 (2), 406-411",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18170435610701254907,122,2011
A model-based approach to insulin adjustment,"S Andreassen, R Hovorka, J Benn, KG Olesen, ER Carson","AIME 91, 239-248",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12404308008488618842,121,1991
Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study,"L Leelarathna, S Dellweg, JK Mader, JM Allen, C Benesch, W Doll, ...","Diabetes Care 37 (7), 1931-1937",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=445698728705745205,120,2014
Blood Glucose Control by a Model Predictive Control Algorithm with Variable Sampling Rate ,"R Hovorka, J Kremen, J Blaha, M Matias, K Anderlova, L Bosanska, ...","The Journal of Clinical Endocrinology & Metabolism 92 (8), 2960-2964",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5573987417773154224,113,2007
Closed-loop insulin delivery during pregnancy in women with type 1 diabetes,"ZA Stewart, ME Wilinska, S Hartnell, RC Temple, G Rayman, KP Stanley, ...","New England Journal of Medicine 375 (7), 644-654",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6949671189710251825,109,2016
Glycemic Variability Correlates Strongly With Postprandialβ-Cell Dysfunction in a Segment of Type 2 Diabetic Patients Using Oral Hypoglycemic Agents,"KD Kohnert, P Augstein, E Zander, P Heinke, K Peterson, EJ Freyse, ...","Diabetes Care 32 (6), 1058-1062","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2983707746260812290,16938818407374681845",106,2009
Effects of intravenous infusion of lipid-free apo AI in humans,"MN Nanjee, JR Crouse, JM King, R Hovorka, SE Rees, ER Carson, ...","Arteriosclerosis, thrombosis, and vascular biology 16 (9), 1203-1214",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4699262641928173986,101,1996
Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents,"KD Barnard, T Wysocki, JM Allen, D Elleri, H Thabit, L Leelarathna, ...","BMJ Open Diabetes Research and Care 2 (1), e000025",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7277796830881928569,97,2014
Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series,"HR Murphy, K Kumareswaran, D Elleri, JM Allen, K Caldwell, M Biagioni, ...","Diabetes care 34 (12), 2527-2529",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12874844710636704457,97,2011
Pancreatic β-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus,"R Hovorka, L Chassin, SD Luzio, R Playle, DR Owens","The Journal of Clinical Endocrinology & Metabolism 83 (3), 744-750",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3349941825097410538,97,1998
"Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics","P Pozzilli, T Battelino, T Danne, R Hovorka, P Jarosz‐Chobot, E Renard","Diabetes/metabolism research and reviews 32 (1), 21-39",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8550177168414122261,96,2016
A simulation model of glucose regulation in the critically ill,"R Hovorka, LJ Chassin, M Ellmerer, J Plank, ME Wilinska","Physiological measurement 29 (8), 959",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3505209662076944914,95,2008
Closed-loop insulin delivery for treatment of type 1 diabetes,"D Elleri, DB Dunger, R Hovorka","BMC medicine 9 (1), 120",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14765107890838519572,93,2011
Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient …,"YM Luijf, JH DeVries, K Zwinderman, L Leelarathna, M Nodale, ...","Diabetes care 36 (12), 3882-3887","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1532284900242996039,13878613482109518886",92,2013
Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis,"E Bekiari, K Kitsios, H Thabit, M Tauschmann, E Athanasiadou, ...","bmj 361, k1310",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7244659812610636593,89,2018
Tight glycaemic control by an automated algorithm with time-variant sampling in medical ICU patients,"C Pachler, J Plank, H Weinhandl, LJ Chassin, ME Wilinska, R Kulnik, ...","Intensive care medicine 34 (7), 1224-1230",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1699524972994399745,88,2008
Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial,"L Leelarathna, SW English, H Thabit, K Caldwell, JM Allen, ...","Critical Care 17 (4), R159",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4789619434436360740,85,2013
A comparison of six deconvolution techniques,"FN Madden, KR Godfrey, MJ Chappell, R Hovorka, RA Bates","Journal of pharmacokinetics and biopharmaceutics 24 (3), 283-299",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2384355328494930425,85,1996
"Day-and-night hybrid closed-loop insulin delivery in adolescents with type 1 diabetes: a free-living, randomized clinical trial","M Tauschmann, JM Allen, ME Wilinska, H Thabit, Z Stewart, P Cheng, ...","Diabetes Care 39 (7), 1168-1174",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17479782664374956231,84,2016
Overnight closed-loop insulin delivery with model predictive control and glucose measurement error model,"ME Wilinska, ES Budiman, GA Hayter, MB Taub, R Hovorka","US Patent 8,062,249",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16497274549591117560,83,2011
The future of continuous glucose monitoring: closed loop,R Hovorka,"Current Diabetes Reviews 4 (3), 269-279",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7527452652230739758,83,2008
How to measure insulin secretion,"R Hovorka, RH Jones","Diabetes/metabolism reviews 10 (2), 91-117",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10800929687788303865,83,1994
Comparison of three protocols for tight glycemic control in cardiac surgery patients,"J Blaha, P Kopecky, M Matias, R Hovorka, J Kunstyr, T Kotulak, M Lips, ...","Diabetes care 32 (5), 757-761",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10400110002435879269,80,2009
Evaluation of glucose controllers in virtual environment: methodology and sample application,"LJ Chassin, ME Wilinska, R Hovorka","Artificial Intelligence in Medicine 32 (3), 171-181",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14131770225214974260,77,2004
Continuous glucose control in the ICU: report of a 2013 round table meeting,"J Wernerman, T Desaive, S Finfer, L Foubert, A Furnary, U Holzinger, ...","Critical care 18 (3), 226",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17663300241870167766,71,2014
Closed-loop insulin delivery in type 1 diabetes,"H Thabit, R Hovorka","Endocrinology and Metabolism Clinics 41 (1), 105-117",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15359790661451581554,70,2012
Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open …,"L Bally, H Thabit, H Kojzar, JK Mader, J Qerimi-Hyseni, S Hartnell, ...","The Lancet Diabetes & Endocrinology 5 (4), 261-270",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10473534420186514008,68,2017
Psychosocial aspects of closed‐and open‐loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting,"KD Barnard, T Wysocki, H Thabit, ML Evans, S Amiel, S Heller, A Young, ...","Diabetic Medicine 32 (5), 601-608",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13185723531205607354,68,2015
Intensive insulin therapy: enhanced Model Predictive Control algorithm versus standard care,"JJ Cordingley, D Vlasselaers, NC Dormand, PJ Wouters, SD Squire, ...","Intensive care medicine 35 (1), 123",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14329594345516611516,67,2009
Management of diabetes using adaptive control,R Hovorka,"International Journal of Adaptive Control and Signal Processing 19 (5), 309-325",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11395605898196527123,67,2005
IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp.,"PV Carroll, ER Christ, AM Umpleby, I Gowrie, N Jackson, SB Bowes, ...","Diabetes 49 (5), 789-796",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2946306613840901987,62,2000
DIAS—the diabetes advisory system: an outline of the system and the evaluation results obtained so far,"OK Hejlesen, S Andreassen, R Hovorka, DA Cavan","Computer methods and programs in biomedicine 54 (1-2), 49-58",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14953509294188225193,62,1997
Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy,"HR Murphy, D Elleri, JM Allen, J Harris, D Simmons, G Rayman, ...","Diabetologia 55 (2), 282-293",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18196627791033158477,61,2012
Measuring prehepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule,"R Hovorka, E Koukkou, D Southerden, JK Powrie, MA Young","Diabetologia 41 (5), 548-554",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3291641779251605015,61,1998
Five-compartment model of insulin kinetics and its use to investigate action of chloroquine in NIDDM,"R Hovorka, JK Powrie, GD Smith, PH Sonksen, ER Carson, RH Jones","American Journal of Physiology-Endocrinology and Metabolism 265 (1), E162-E175",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14980226005675118454,59,1993
Closed-loop insulin delivery for glycemic control in noncritical care,"L Bally, H Thabit, S Hartnell, E Andereggen, Y Ruan, ME Wilinska, ...","New England Journal of Medicine 379 (6), 547-556","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10291109273391324782,1247174891138376891",58,2018
Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies,"ME Wilinska, ES Budiman, MB Taub, D Elleri, JM Allen, CL Acerin, ...","Journal of diabetes science and technology 3 (5), 1109-1120",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4035487350677587086,58,2009
On‐line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with type 1 diabetes,"HC Schaller, L Schaupp, M Bodenlenz, ME Wilinska, LJ Chassin, P Wach, ...","Diabetic medicine 23 (1), 90-93",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4657742613214926383,56,2006
Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range,"T Battelino, T Danne, RM Bergenstal, SA Amiel, R Beck, T Biester, E Bosi, ...","Diabetes Care 42 (8), 1593-1603",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4257242678489416046,55,2019
Roadmap to the artificial pancreas,"R Hovorka, ME Wilinska, LJ Chassin, DB Dunger","Diabetes research and clinical practice 74, S178-S182",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15722762435683325764,55,2006
Glucose control in the ICU: a continuing story,"JC Preiser, JG Chase, R Hovorka, JI Joseph, JS Krinsley, C De Block, ...","Journal of diabetes science and technology 10 (6), 1372-1381",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1806181237103771339,54,2016
Automated overnight closed-loop glucose control in young children with type 1 diabetes,"D Elleri, JM Allen, M Nodale, ME Wilinska, JS Mangat, AMF Larsen, ...","Diabetes technology & therapeutics 13 (4), 419-424",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14135251327417816710,54,2011
"Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial","M Tauschmann, H Thabit, L Bally, JM Allen, S Hartnell, ME Wilinska, ...","The Lancet 392 (10155), 1321-1329","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9473041053752291908,15968254046433314883",53,2018
Methods for reducing false hypoglycemia alarm occurrence,"ES Budiman, GA Hayter, MB Taub, R Hovorka, M Wilinska, D Dunger","US Patent 9,579,456",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8878886592153769696,53,2017
"Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial","H Thabit, S Hartnell, JM Allen, A Lake, ME Wilinska, Y Ruan, ML Evans, ...","The Lancet Diabetes & Endocrinology 5 (2), 117-124",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7558389522125753887,53,2017
Quantifying the acute changes in glucose with exercise in type 1 diabetes: a systematic review and meta-analysis,"F Garcia-Garcia, K Kumareswaran, R Hovorka, ME Hernando","Sports medicine 45 (4), 587-599",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6066906219241466038,52,2015
Simulation models for in silico testing of closed-loop glucose controllers in type 1 diabetes,"ME Wilinska, R Hovorka","Drug Discovery Today: Disease Models 5 (4), 289-298",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=176019538422497213,52,2008
Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance,"FM Regan, RM Williams, A McDonald, AM Umpleby, CL Acerini, ...","The Journal of Clinical Endocrinology & Metabolism 95 (5), 2113-2122",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=162979293893852589,51,2010
Technosphere® insulin suppresses endogenous glucose production earlier than a rapid-acting analog (lispro) and an inhaled insulin (exubera),"E Potocka, R Hovorka, RA Baughman, M Umpleby, M Diaz, R Chen, ...","Diabetologia 52 (Suppl 1), S374",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5240039813043896508,51,2009
Artificial pancreas: an emerging approach to treat Type 1 diabetes,"K Kumareswaran, ML Evans, R Hovorka","Expert review of medical devices 6 (4), 401-410",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16005887583273961954,50,2009
Evaluation of a portable ambulatory prototype for automated overnight closed‐loop insulin delivery in young people with type 1 diabetes,"D Elleri, JM Allen, M Biagioni, K Kumareswaran, L Leelarathna, ...","Pediatric diabetes 13 (6), 449-453",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15560332010833350613,49,2012
Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes,"D Elleri, CL Acerini, JM Allen, J Hayes, C Pesterfield, ME Wilinska, ...","Diabetes technology & therapeutics 12 (1), 35-39",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11637584316693963446,49,2010
Assessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: drawbacks and way forward,"R Hovorka, M Nodale, A Haidar, ME Wilinska","Diabetes technology & therapeutics 15 (1), 4-12",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16917487367923997711,47,2013
Characterization of metabolism parameters following Technosphere® insulin and insulin Lispro,"E Potocka, R Hovorka, R Baughman, O Klein, S Dellweg, M Umpleby, ...","Diabetes 59 (Suppl 1), A413",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4206603737425468357,47,2010
Perioperative tight glucose control reduces postoperative adverse events in nondiabetic cardiac surgery patients,"J Bláha, M Mráz, P Kopecký, M Stříteský, M Lipš, M Matias, J Kunstýř, ...","The Journal of Clinical Endocrinology & Metabolism 100 (8), 3081-3089",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11548619539472835311,45,2015
Prandial hypertriglyceridemia in metabolic syndrome is due to an overproduction of both chylomicron and VLDL triacylglycerol,"F Shojaee-Moradie, Y Ma, S Lou, R Hovorka, AM Umpleby","Diabetes 62 (12), 4063-4069","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3591564001765039035,17145226420687480885",45,2013
Causal probabilistic network modeling—illustration of its role in the management of chronic diseases,"R Hovorka, S Andreassen, JJ Benn, KG Olesen, ER Carson","IBM Systems Journal 31 (4), 635-648",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17936439324510336717,44,1992
Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems,"L Leelarathna, M Nodale, JM Allen, D Elleri, K Kumareswaran, A Haidar, ...","Diabetes technology & therapeutics 15 (2), 143-149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8174682811837234817,43,2013
A consultation system for insulin therapy,"R Hovorka, Š Svačina, ER Carson, CD Williams, PH Sönksen","Computer methods and programs in biomedicine 32 (3-4), 303-310",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13876997268459491147,42,1990
Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrations,"L Leelarathna, SW English, H Thabit, K Caldwell, JM Allen, ...","Diabetes technology & therapeutics 16 (2), 97-101",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1755364915645268473,41,2014
"Home use of day-and-night hybrid closed-loop insulin delivery in suboptimally controlled adolescents with type 1 diabetes: a 3-week, free-living, randomized crossover trial","M Tauschmann, JM Allen, ME Wilinska, H Thabit, CL Acerini, DB Dunger, ...","Diabetes Care 39 (11), 2019-2025",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4648508574292151677,40,2016
Closed-loop insulin delivery: towards improved diabetes care,"K Kumareswaran, ML Evans, R Hovorka","Discovery medicine 13 (69), 159-170",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12990818506103004557,40,2012
Attainment of metabolic goals in the integrated UK islet transplant program with locally isolated and transported preparations,"AM Brooks, N Walker, A Aldibbiat, S Hughes, G Jones, J De Havilland, ...","American Journal of Transplantation 13 (12), 3236-3243",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16642374706244696519,39,2013
Suspended insulin infusion during overnight closed‐loop glucose control in children and adolescents with Type 1 diabetes,"D Elleri, JM Allen, M Nodale, ME Wilinska, CL Acerini, DB Dunger, ...","Diabetic Medicine 27 (4), 480-484",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=51227414979503275,39,2010
Preliminary experience of the DIAS computer model in providing insulin dose advice to patients with insulin dependent diabetes,"DA Cavan, OK Hejlesen, R Hovorka, JA Evans, JA Metcalfe, ML Cavan, ...","Computer Methods and programs in Biomedicine 56 (2), 157-164",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5120581799400092631,39,1998
Effect of growth hormone treatment on postprandial protein metabolism in growth hormone-deficient adults,"DL Russell-Jones, SB Bowes, SE Rees, NC Jackson, AJ Weissberger, ...","American Journal of Physiology-Endocrinology and Metabolism 274 (6), E1050-E1056",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14742937129714981751,38,1998
Using a double blind controlled clinical trial to evaluate the function of a Diabetes Advisory System: a feasible approach?,"OK Hejlesen, S Andreassen, NE Frandsen, TB Sørensen, SH Sandø, ...","Computer methods and programs in biomedicine 56 (2), 165-173",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5923889830425386541,38,1998
Feasibility of closed-loop insulin delivery in type 2 diabetes: a randomized controlled study,"K Kumareswaran, H Thabit, L Leelarathna, K Caldwell, D Elleri, JM Allen, ...","Diabetes Care 37 (5), 1198-1203",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2855887056335982991,37,2014
Interstitial glucose kinetics in subjects with type 1 diabetes under physiologic conditions,"ME Wilinska, M Bodenlenz, LJ Chassin, HC Schaller, LA Schaupp, ...","Metabolism 53 (11), 1484-1491",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3987906005935575815,37,2004
Quantitative Measurement of 3‐,"F Shojaee‐Moradie, NC Jackson, RH Jones, AI Mallet, R Hovorka, ...","Journal of Mass Spectrometry 31 (9), 961-966",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13965573273968905684,37,1996
"Closing the loop in adults, children and adolescents with suboptimally controlled type 1 diabetes under free living conditions: a psychosocial substudy","KD Barnard, T Wysocki, V Ully, JK Mader, TR Pieber, H Thabit, ...","Journal of diabetes science and technology 11 (6), 1080-1088",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3682120245530895489,36,2017
Glucose control in the intensive care unit by use of continuous glucose monitoring: what level of measurement error is acceptable?,"ME Wilinska, R Hovorka","Clinical chemistry 60 (12), 1500-1509",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2461508567804926947,36,2014
"Pharmacokinetics of insulin aspart in pump-treated subjects with type 1 diabetes: reproducibility and effect of age, weight, and duration of diabetes","A Haidar, D Elleri, K Kumareswaran, L Leelarathna, JM Allen, K Caldwell, ...","Diabetes care 36 (10), e173-e174",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8483196832555469211,36,2013
Day-and-night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: a randomized controlled crossover trial,"ZA Stewart, ME Wilinska, S Hartnell, LK O’Neil, G Rayman, EM Scott, ...","Diabetes Care 41 (7), 1391-1399",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2676598417395874685,35,2018
The use of continuous glucose monitoring combined with computer-based eMPC algorithm for tight glucose control in cardiosurgical ICU,"P Kopecký, M Mráz, J Bláha, J Lindner, Š Svačina, R Hovorka, M Haluzík",BioMed research international 2013,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15334192651599591074,35,2013
Stochastic virtual population of subjects with type 1 diabetes for the assessment of closed-loop glucose controllers,"A Haidar, ME Wilinska, JA Graveston, R Hovorka","IEEE Transactions on Biomedical Engineering 60 (12), 3524-3533",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4520811249303308928,34,2013
Accuracy of continuous glucose monitoring during exercise in type 1 diabetes pregnancy,"K Kumareswaran, D Elleri, JM Allen, K Caldwell, M Nodale, ME Wilinska, ...","Diabetes technology & therapeutics 15 (3), 223-229",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=761734740943074792,34,2013
Meta-analysis of overnight closed-loop randomized studies in children and adults with type 1 diabetes: the Cambridge cohort,"K Kumareswaran, D Elleri, JM Allen, J Harris, D Xing, C Kollman, ...","Journal of diabetes science and technology 5 (6), 1352-1362",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14598003129938288560,34,2011
CODE: a deconvolution program implementing a regularization method of deconvolution constrained to non‐negative values. Description and pilot evaluation,"R Hovorka, MJ Chappell, KR Godfrey, FN Madden, MK Rouse, PA Soons","Biopharmaceutics & drug disposition 19 (1), 39-53",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9285510606413707950,34,1998
Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons,"H Thabit, R Hovorka","Expert opinion on drug delivery 13 (3), 389-400",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15194824337700941571,33,2016
Accuracy of continuous glucose monitoring during three closed-loop home studies under free-living conditions,"H Thabit, L Leelarathna, ME Wilinska, D Elleri, JM Allen, ...","Diabetes technology & therapeutics 17 (11), 801-807",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5801435462691881572,33,2015
Absorption patterns of meals containing complex carbohydrates in type 1 diabetes,"D Elleri, JM Allen, J Harris, K Kumareswaran, M Nodale, L Leelarathna, ...","Diabetologia 56 (5), 1108-1117",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5997957250383313760,33,2013
Efficacy and safety of glucose control with Space GlucoseControl in the medical intensive care unit—an open clinical investigation,"K Amrein, M Ellmerer, R Hovorka, N Kachel, H Fries, D Von Lewinski, ...","Diabetes technology & therapeutics 14 (8), 690-695",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=400820450763108672,31,2012
Effects of prolonged fasting and sustained lipolysis on insulin secretion and insulin sensitivity in normal subjects,"B Salgin, ML Marcovecchio, SM Humphreys, N Hill, LJ Chassin, DJ Lunn, ...","American Journal of Physiology-Endocrinology and Metabolism 296 (3), E454-E461",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4294519365768361925,31,2009
 Testing—Impact on the Progress of the Closed Loop Insulin Infusion for Critically Ill Patients Project,"ME Wilinska, LJ Chassin, R Hovorka","Journal of diabetes science and technology 2 (3), 417-423",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3730647641480827874,30,2008
Variability of insulin requirements over 12 weeks of closed-loop insulin delivery in adults with type 1 diabetes,"Y Ruan, H Thabit, L Leelarathna, S Hartnell, ME Willinska, S Dellweg, ...","Diabetes Care 39 (5), 830-832",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1127573067379119508,29,2016
Calculating glucose fluxes during meal tolerance test: a new computational approach,"R Hovorka, H Jayatillake, E Rogatsky, V Tomuta, T Hovorka, DT Stein","American Journal of Physiology-Endocrinology and Metabolism 293 (2), E610-E619",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7216118268070074453,29,2007
Safety of closed‐loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trial,"D Elleri, G Maltoni, JM Allen, M Nodale, K Kumareswaran, L Leelarathna, ...","Diabetes, Obesity and Metabolism 16 (11), 1174-1178",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2550818677517434841,28,2014
Fitting dynamic models with forcing functions: application to continuous glucose monitoring in insulin therapy,"DJ Lunn, C Wei, R Hovorka","Statistics in medicine 30 (18), 2234-2250",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5308673166608826154,28,2011
Population and individual minimal modeling of the frequently sampled insulin-modified intravenous glucose tolerance test,"L Erichsen, OF Agbaje, SD Luzio, DR Owens, R Hovorka","Metabolism 53 (10), 1349-1354",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7942145560504159082,28,2004
Bayesian hierarchical approach to estimate insulin sensitivity by minimal model,"OF Agbaje, SD Luzio, AIS Albarrak, DR OWENS, R HOVORKA","Clinical science 105 (5), 551-560",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3253276427867784585,28,2003
Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3–6 years: comparison between diluted and standard insulin strength,"D Elleri, JM Allen, M Tauschmann, R El-Khairi, P Benitez-Aguirre, ...","BMJ Open Diabetes Research and Care 2 (1), e000040",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7488915897394026224,27,2014
Measurement delay associated with the Guardian® RT continuous glucose monitoring system,"C Wei, DJ Lunn, CL Acerini, JM Allen, AM Larsen, ME Wilinska, ...","Diabetic Medicine 27 (1), 117-122",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12519548782877317778,27,2010
Associations of glucose control with insulin sensitivity and pancreatic β-cell responsiveness in newly presenting type 2 diabetes,"AI Albarrak, SD Luzio, LJ Chassin, RA Playle, DR Owens, R Hovorka","The Journal of Clinical Endocrinology & Metabolism 87 (1), 198-203",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5044629941235810924,27,2002
Unsupervised home use of an overnight closed‐loop system over 3–4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes,"H Thabit, D Elleri, L Leelarathna, JM Allen, A Lubina‐Solomon, M Stadler, ...","Diabetes, Obesity and Metabolism 17 (5), 452-458",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6826409325549861281,26,2015
Evaluation of nonlinear regression approaches to estimation of insulin sensitivity by the minimal model with reference to Bayesian hierarchical analysis,"IF Godsland, OF Agbaje, R Hovorka","American Journal of Physiology-Endocrinology and Metabolism 291 (1), E167-E174",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14300314233187926288,26,2006
DIAS–NIDDM—a model-based decision support system for insulin dose adjustment in insulin-treated subjects with NIDDM,"RS Tudor, R Hovorka, DA Cavan, D Meeking, OK Hejlesen, ...","Computer methods and programs in biomedicine 56 (2), 175-192",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17065167911747793562,25,1998
Use of the DIAS model to predict unrecognised hypoglycaemia in patients with insulin-dependent diabetes,"DA Cavan, R Hovorka, OK Hejlesen, S Andreassen, PH Sönksen","Computer methods and programs in biomedicine 50 (3), 241-246",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15318554499975586746,25,1996
Technology in the management of type 1 diabetes mellitus—current status and future prospects,"M Tauschmann, R Hovorka","Nature Reviews Endocrinology 14 (8), 464-475",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11109789380608109779,24,2018
Substance monitoring and control in human or animal bodies,R Hovorka,"US Patent 9,089,305","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8139732533061322118,1475730306540792654",24,2015
Evaluation of implementation of a fully automated algorithm (enhanced model predictive control) in an interacting infusion pump system for establishment of tight glycemic …,"R Kulnik, J Plank, C Pachler, ME Wilinska, A Groselj-Strele, D Röthlein, ...","Journal of diabetes science and technology 2 (6), 963-970",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2433316887736513336,24,2008
Bringing closed-loop home: recent advances in closed-loop insulin delivery,"H Thabit, R Hovorka","Current Opinion in Endocrinology, Diabetes and Obesity 21 (2), 95-101",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3802394699754982889,23,2014
"Glucose control in intensive care: usability, efficacy and safety of Space GlucoseControl in two medical European intensive care units","K Amrein, N Kachel, H Fries, R Hovorka, TR Pieber, J Plank, U Wenger, ...","BMC endocrine disorders 14 (1), 62",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=445488786324192842,22,2014
Hospital glucose control: safe and reliable glycemic control using enhanced model predictive control algorithm in medical intensive care unit patients,"K Amrein, M Ellmerer, R Hovorka, N Kachel, D Parcz, S Korsatko, ...","Diabetes technology & therapeutics 12 (5), 405-412",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17585706473662856558,22,2010
Grading system to assess clinical performance of closed-loop glucose control,"LJ Chassin, ME Wilinska, R Hovorka","Diabetes technology & therapeutics 7 (1), 72-82",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13664780313783793940,22,2005
Analysing the hypoglycaemic counter-regulation: a clinically relevant phenomenon?,"OK Hejlesen, S Andreassen, DA Cavan, R Hovorka","Computer methods and programs in biomedicine 50 (3), 231-240",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9555317879346109180,22,1996
Computer models of albumin and haemoglobin glycation,"Š Svačina, R Hovorka, J Škrha","Computer methods and programs in biomedicine 32 (3-4), 259-263",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3088792022094669381,22,1990
Experiences of closed‐loop insulin delivery among pregnant women with Type 1 diabetes,"C Farrington, ZA Stewart, K Barnard, R Hovorka, HR Murphy","Diabetic Medicine 34 (10), 1461-1469",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15798486755965158880,21,2017
Glucose-responsive insulin delivery for type 1 diabetes: The artificial pancreas story,"L Bally, H Thabit, R Hovorka","International journal of pharmaceutics 544 (2), 309-318",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5651073451737005942,20,2018
Modeling day-to-day variability of glucose–insulin regulation over 12-week home use of closed-loop insulin delivery,"Y Ruan, ME Wilinska, H Thabit, R Hovorka","IEEE Transactions on Biomedical Engineering 64 (6), 1412-1419",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8070983178591965406,20,2016
Glucose control in non‐critically ill inpatients with diabetes: towards closed‐loop,"H Thabit, R Hovorka","Diabetes, Obesity and Metabolism 16 (6), 500-509",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14739427637753453500,20,2014
Physical activity energy expenditure and glucose control in pregnant women with type 1 diabetes: is 30 minutes of daily exercise enough?,"K Kumareswaran, D Elleri, JM Allen, K Caldwell, K Westgate, S Brage, ...","Diabetes Care 36 (5), 1095-1101",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3108608960942251280,20,2013
Validity of triple-and dual-tracer techniques to estimate glucose appearance,"A Haidar, D Elleri, JM Allen, J Harris, K Kumareswaran, M Nodale, ...","American Journal of Physiology-Endocrinology and Metabolism 302 (12), E1493 …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4517235937313199543,20,2012
Evaluating glycemic control algorithms by computer simulations,"ME Wilinska, J Blaha, LJ Chassin, JJ Cordingley, NC Dormand, ...","Diabetes technology & therapeutics 13 (7), 713-722",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1344000755060156087,20,2011
Insulin administration and rate of glucose appearance in people with type 1 diabetes,"ME Pennant, LJC Bluck, ML Marcovecchio, B Salgin, R Hovorka, ...","Diabetes Care 31 (11), 2183-2187",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16924427505401511029,20,2008
Automated glucose control in the ICU: effect of nutritional protocol and measurement error,"ME Wilinska, LJ Chassin, R Hovorka",2006 International Conference of the IEEE Engineering in Medicine and …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5794540423912364848,20,2006
Closed-loop for type 1 diabetes–an introduction and appraisal for the generalist,"L Bally, H Thabit, R Hovorka","BMC medicine 15 (1), 14",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3962080153320890143,19,2017
Unsupervised overnight closed loop insulin delivery during free living: analysis of randomised cross-over home studies in adults and adolescents with type 1 diabetes,"H Thabit, D Elleri, L Leelarathna, J Allen, A Lubina-Solomon, M Stadler, ...","The Lancet 385, S96",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10483150760795153139,19,2015
Gender Differences in VLDL,"I Sarac, K Backhouse, F Shojaee-Moradie, M Stolinski, MD Robertson, ...","The Journal of Clinical Endocrinology & Metabolism 97 (7), 2475-2481",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5055116900818945005,18,2012
Reproducibility and comparability of insulin sensitivity indices measured by stable‐label intravenous glucose tolerance test,"R Hovorka, P Bannister, DJA Eckland, D Halliday, DN Murley, SE Rees, ...","Diabetic medicine 15 (3), 234-246",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6927633200736049666,18,1998
"Safety, efficacy and glucose turnover of reduced prandial boluses during closed‐loop therapy in adolescents with type 1 diabetes: a randomized clinical trial","D Elleri, M Biagioni, JM Allen, K Kumareswaran, L Leelarathna, ...","Diabetes, Obesity and Metabolism 17 (12), 1173-1179",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1717053129500535815,17,2015
Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study …,"L Leelarathna, S Dellweg, JK Mader, K Barnard, C Benesch, M Ellmerer, ...","BMJ open 4 (9), e006075",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2649208031403541512,17,2014
Parameter estimation,"R Hovorka, P Vicini","Modeling Methodology for Physiology and Medicine, 107-151",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2056457523635727258,17,2001
Constant infusion and bolus injection of stable-label tracer give reproducible and comparable fasting HGO,"R Hovorka, DJ Eckland, D Halliday, S Lettis, CE Robinson, P Bannister, ...","American Journal of Physiology-Endocrinology And Metabolism 273 (1), E192-E201",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11954390625510543640,17,1997
Computers in diabetes,"R Hovorka, ER Carson","Computer Methods and Programs in Biomedicine 41 (3-4), 151-152",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9603527493519296112,17,1994
Pharmacokinetics of insulin aspart in pregnant women with type 1 diabetes: every day is different,"RJB Goudie, D Lunn, R Hovorka, HR Murphy","Diabetes Care 37 (6), e121-e122",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15754059140201496524,16,2014
Intense exercise in type 1 diabetes: exploring the role of continuous glucose monitoring,"LJ Chassin, ME Wilinska, R Hovorka","Journal of diabetes science and technology 1 (4), 570-573",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4866264022985927749,16,2007
Computers in diabetes: an introduction,"ER Carson, S Andreassen, DA Cavan, EJ Gómez","Computer methods and programs in biomedicine 62 (3), 153-155","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8368037398186994677,4532612412891927201",16,2000
Is an artificial pancreas (closed‐loop system) for Type 1 diabetes effective?,"CK Boughton, R Hovorka","Diabetic Medicine 36 (3), 279-286",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10572738600908609485,15,2019
Patients’ and caregivers’ experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study,"J Lawton, M Blackburn, J Allen, F Campbell, D Elleri, L Leelarathna, ...","BMC endocrine disorders 18 (1), 12",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12421776762598456034,15,2018
Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems,"M Tauschmann, R Hovorka","Expert opinion on drug delivery 11 (6), 943-955",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14159290005845373456,15,2014
Mass kinetics of apolipoprotein AI in interstitial fluid after administration of intravenous apolipoprotein AI/lecithin discs in humans,"R Hovorka, MN Nanjee, CJ Cooke, IP Miller, WL Olszewski, NE Miller","Journal of lipid research 47 (5), 975-981",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16046734404891153988,15,2006
Relation between insulin kinetics and insulin sensitivity in pregnancy,"MC Jolly, R Hovorka, I Godsland, R Amin, N Lawrence, V Anyaoku, ...","European journal of clinical investigation 33 (8), 698-703",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3042995168980203676,15,2003
Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3–6 years with type 1 diabetes during closed-loop insulin delivery: a randomised …,"Y Ruan, D Elleri, JM Allen, M Tauschmann, ME Wilinska, DB Dunger, ...","Diabetologia 58 (4), 687-690",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3134144851840859442,14,2015
Tracing lipid metabolism: the value of stable isotopes,AM Umpleby,"J. Endocrinol 226, G1-G10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17691359319113374097,14,2015
Risk calculation of type 2 diabetes,"T Haas, S Svacina, J Pav, R Hovorka, P Sucharda, J Sonka","Computer methods and programs in biomedicine 41 (3-4), 297-303",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8064757935086554874,14,1994
Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and …,"L Bally, H Thabit, M Tauschmann, JM Allen, S Hartnell, ME Wilinska, ...","BMJ open 7 (7), e016738",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=857910219841381695,13,2017
Artificial pancreas project at Cambridge 2013,R Hovorka,"Diabetic Medicine 32 (8), 987-992",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5741552559412071525,13,2015
Lipohypertrophy and the artificial pancreas: is this an issue?,"L Heinemann, L Hirsch, R Hovorka","Journal of diabetes science and technology 8 (5), 915-917",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15574265439645169671,13,2014
Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids,"AL Brackenridge, N Jackson, W Jefferson, M Stolinski, ...","Diabetic Medicine 26 (5), 532-539",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1064677396378375469,13,2009
"Home use of day-and-night hybrid closed-loop insulin delivery in very young children: a multicenter, 3-week, randomized trial","M Tauschmann, JM Allen, K Nagl, M Fritsch, J Yong, E Metcalfe, ...","Diabetes care 42 (4), 594-600",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9902228209640959723,12,2019
Estimating postprandial glucose fluxes using hierarchical Bayes modelling,"A Haidar, E Potocka, B Boulet, AM Umpleby, R Hovorka","Computer methods and programs in biomedicine 108 (1), 102-112",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17607260761777068111,12,2012
Improving glycemic control in critically ill patients: personalized care to mimic the endocrine pancreas,"JG Chase, T Desaive, J Bohe, M Cnop, C De Block, J Gunst, R Hovorka, ...","Critical care 22 (1), 182",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17411669756755547990,11,2018
Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets,"AM Umpleby, F Shojaee-Moradie, B Fielding, X Li, A Marino, N Alsini, ...","Clinical Science 131 (21), 2561-2573",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4946376249921233061,11,2017
Closed-loop in children with type 1 diabetes: Specific challenges,"D Elleri, JM Allen, DB Dunger, R Hovorka","Diabetes research and clinical practice 93, S131-S135",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9771601272718069819,11,2011
The artificial pancreas: making headway,"R Hovorka, M E Wilinska, L J Chassin, C L Acerini, D B Dunger","Practical Diabetes International 24 (2), 56-58",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14299890433628927775,11,2007
Acid-base chemistry of the blood—a general model,"SE Rees, S Andreassen, R Hovorka, R Summers, ER Carson","Computer methods and programs in biomedicine 51 (1-2), 107-119",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7563461178089793588,11,1996
Computers in diabetes-Introduction,"ER Carson, R Hovorka, S Andreassen","Computer Methods and Programs in Biomedicine 50 (3), 207-208",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8277818725397917752,11,1996
A COMPUTER-PROGRAM TO RECONSTRUCT INSULIN-SECRETION,R Hovorka,"Diabetologia 36, A68-A68",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13607563517800225966,11,1993
A validation methodology for testing decision-support systems for insulin dosage adjustment,"AV Roudsari, HJ Leicester, ED Lehmann, R Hovorka, S Andreassen, ...","Medical Informatics Europe 1991, 382-388",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16236331369012064901,11,1991
"Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial","CK Boughton, L Bally, F Martignoni, S Hartnell, D Herzig, A Vogt, ...","The Lancet Diabetes & Endocrinology 7 (5), 368-377",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9367838193067925874,10,2019
Finding the right route for insulin delivery–an overview of implantable pump therapy,"L Bally, H Thabit, R Hovorka","Expert opinion on drug delivery 14 (9), 1103-1111",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5191128832310754563,10,2017
A stepwise approach toward closed-loop blood glucose control for intensive care unit patients: results from a feasibility study in type 1 diabetic subjects using vascular …,"F Feichtner, JK Mader, R Schaller, L Schaupp, M Ellmerer, S Korsatko, ...","Journal of diabetes science and technology 5 (4), 901-905",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9481823620174923823,10,2011
Feasibility of the SC-SC route for an extracorporeal artificial pancreas,HC Schaller,"Diabetes Suppl 2 51, A114, 462-P",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14234749595200208681,10,2002
Relationship between β‐cell responsiveness and fasting plasma glucose in Caucasian subjects with newly presenting Type 2 diabetes,"R Hovorka, A Albarrak, L Chassin, SD Luzio, R Playle, DR Owens","Diabetic medicine 18 (10), 797-802",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5893242171316283896,10,2001
Dynamic updating in DIAS-NIDDM and DIAS causal probabilistic networks,"R Hovorka, RS Tudor, D Southerden, DR Meeking, S Andreassen, ...","IEEE transactions on biomedical engineering 46 (2), 158-168",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2470629125782711585,10,1999
A vision of information technology support for diabetes care,"C Binder, L Fletcher, R Hovorka, M MASSI BENEDETTI, LH NIELSEN, ...","Diabetes, nutrition & metabolism 8 (4), 205-214",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3675449245454672452,10,1995
Advances in artificial pancreas systems,"CK Boughton, R Hovorka","Science translational medicine 11 (484), eaaw4949",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=233923517496840632,9,2019
Overnight sc-sc closed-loop control improves glucose control and reduces risk of hypoglycaemia in children and adolescents with type 1 diabetes,"R Hovorka, CL Acerini, J Allen, LJ Chassin, AM Larsen, A De Palma, ...","Diabetes 57, A22-A22",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5229100056133153672,9,2008
Holistic impact of closed-loop technology on people with type 1 diabetes,"AJ Young, H Thabit, SR Heller, ML Evans, SA Amiel, R Hovorka, ...","Journal of diabetes science and technology 9 (4), 932",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8575496319081146794,8,2015
A novel method for measuring intestinal and hepatic triacylglycerol kinetics,"F Sun, M Stolinski, F Shojaee-Moradie, S Lou, Y Ma, R Hovorka, ...","American Journal of Physiology-Endocrinology and Metabolism 305 (8), E1041-E1047",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=40888615588171853,8,2013
AFRESA (TM) Suppresses Endogenous Glucose Production Earlier Than a Rapid-Acting Analog (Lispro) and Inhaled Exubera (R),"E Potocka, R Hovorka, RA Baughman, M Umpleby, MLM Diaz, R Chen, ...","Diabetes 58, A61-A61",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4425037733469216382,8,2009
Evaluation of a feedback model based on simulated interstitial glucose for continous insulin infusion,"V Canonico, MO Federici, P Ferolla, R Calleno, J Akwe, A Timi, L Chassin, ...","Diabetologia 45, A322-A322",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=406642241745501840,8,2002
The role of a diabetic advisory system (dias) in the management of insulin-dependent diabetes mellitus,"M Halim, ER Carson, S Andreassen, O Hejlesen, R Hovorka",Proceedings of the 15th Annual International Conference of the IEEE …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9273147860370590379,8,1993
Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis,"L Bally, P Gubler, H Thabit, S Hartnell, Y Ruan, ME Wilinska, ML Evans, ...",Kidney international,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5913505158662615553,7,2019
Bridging technology and clinical practice: innovating inpatient hyperglycaemia management in non‐critical care settings,"H Thabit, R Hovorka","Diabetic Medicine 35 (4), 460-471",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4633237234194075895,7,2018
Behavioral patterns and associations with glucose control during 12-week randomized free-living clinical trial of day and night hybrid closed-loop insulin delivery in adults …,"A Emami, ME Willinska, H Thabit, L Leelarathna, S Hartnell, S Dellweg, ...","Diabetes technology & therapeutics 19 (7), 433-437",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5977797373924930201,7,2017
Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery,"Y Ruan, H Thabit, ME Wilinska, R Hovorka","Biomedical engineering online 14 (1), 19",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13583494058284216802,7,2015
Evaluating the performance of a novel embedded closed-loop system,"L Leelarathna, H Thabit, JM Allen, M Nodale, ME Wilinska, K Powell, ...","Journal of diabetes science and technology 8 (2), 267-272",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4427648720480374547,7,2014
Plasma C‐peptide concentration in women with Type 1 diabetes during early and late pregnancy,"HR Murphy, D Elleri, JM Allen, D Simmons, M Nodale, R Hovorka","Diabetic Medicine 29 (10), e361-e364",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7937971163701000212,7,2012
Day-and-night closed-loop (CL) glucose control in adolescents with type 1 diabetes (T1D),"D Elleri, JM Allen, K Kumareswaran, L Leelarathna, M Nodale, K Caldwell, ...","Diabetes 60, A41-A42",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17202638827480592504,7,2011
Parenteral glucose and glucose control in the critically ill: a kinetic appraisal,"R Hovorka, J Cordingley","Journal of diabetes science and technology 1 (3), 357-365",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7408062183838153911,7,2007
The Diabetes Advisory System-an IT approach to the management of insulin dependent diabetes,"S Andreassen, OK Hejlesen, R Hovorka, DA Cavan","Studies in Health Technology and Informatics, 1079-1083",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6430416741343106480,7,1996
"Adaptability of closed loop during labor, delivery, and postpartum: a secondary analysis of data from two randomized crossover trials in type 1 diabetes pregnancy","ZA Stewart, JM Yamamoto, ME Wilinska, S Hartnell, C Farrington, ...","Diabetes technology & therapeutics 20 (7), 501-505",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8384230660412606334,6,2018
Closing the Loop,"R Nimri, H Yakoob, B Schoenberg, E Dassau, DR Cherñavvsky, ...","Diabetes technology & therapeutics 18 (S1), S-29-S-42",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12170521106635284033,6,2016
Rapid model exploration for complex hierarchical data: application to pharmacokinetics of insulin aspart,"RJB Goudie, R Hovorka, HR Murphy, D Lunn","Statistics in medicine 34 (23), 3144-3158",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17833955587409757236,6,2015
Simulation Models for In-Silico Evaluation of Closed-Loop Insulin Delivery Systems in Type 1 Diabetes,"ME Wilinska, R Hovorka","Data-driven Modeling for Diabetes, 131-149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4627295866295812461,6,2014
Further development of artificial pancreas: blocked by patents?,"N Erdin, F Robin, L Heinemann, D Brandt, R Hovorka","Journal of diabetes science and technology 2 (6), 971-976",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6433950113207546068,6,2008
In silico simulation environment and glucose control in critically Ill subjects: strategic considerations,"R Hovorka, ME Wilinska, LJ Chassin","3rd European Medical & Biological Engineering Conference, 20-25",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8679463332487468946,6,2005
Partitioning glucose transport/distribution and disposal during euglycaemic clamp,"F Shojaee-Moradie, PV Carroll, LJ Chassin, IJ Gowrie, NC Jackson, ...","Diabetologia 44, A206-A206",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6729571741908703070,6,2001
Identification of insulin receptor systems: assessing the impact of model selection and measurement error on precision of parameter estimates using Monte Carlo study,"R Hovorka, J Hilgertova","Journal of theoretical biology 151 (3), 367-383",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5795304706209823605,6,1991
"The impact of using a closed‐loop system on food choices and eating practices among people with Type 1 diabetes: a qualitative study involving adults, teenagers and parents","J Lawton, M Blackburn, D Rankin, J Allen, F Campbell, L Leelarathna, ...","Diabetic Medicine 36 (6), 753-760",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16243782632699419259,5,2019
Bolusing frequency and amount impacts glucose control during hybrid closed‐loop,"L Bally, H Thabit, Y Ruan, JK Mader, H Kojzar, S Dellweg, C Benesch, ...","Diabetic medicine 35 (3), 347-351",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10113718931227012835,5,2018
Available at a flash: a new way to check glucose,"H Thabit, L Bally, R Hovorka",Elsevier,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11247866301594215632,5,2016
Pharmacokinetics of insulin lispro in type 2 diabetes during closed-loop insulin delivery,"Y Ruan, H Thabit, K Kumareswaran, R Hovorka","Computer methods and programs in biomedicine 117 (2), 298-307",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8292156721395698739,5,2014
Method of overnight closed-loop insulin delivery with model predictive control and glucose measurement error model,"ME Wilinska, ES Budiman, GA Hayter, MB Taub, R Hovorka","US Patent 8,585,637",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16987274377239676088,5,2013
"Good overnight closed-loop glucose control in children and adolescents with type 1 diabetes following ingestion of large, rapidly and slowly absorbed evening meat","R Hovorka, CL Acerini, J Allen, LJ Chassin, AF Larsen, D Mundt, ...","Diabetologia 51, S81-S81",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2211995357452008902,5,2008
Closed-loop glucose control with IV glucose sampling and SC insulin infusion: evaluation by simulation studies,"LJ Chassin, R Hovorka","Diabetologia 44, A58-A58",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15417625145960141761,5,2001
Modelling and decision support in physiology and medicine: a methodological framework with lllustration,"ER Carson, R Hovorka, AV Roudsari, R Summers","Mathematical and Computer Modelling of Dynamical Systems 4 (1), 73-99",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11969827083821711008,5,1998
Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery,"K Dovc, C Boughton, M Tauschmann, H Thabit, L Bally, JM Allen, ...","Diabetes Care 42 (7), 1344-1347",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8549974965916905717,4,2019
"Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study","J Lawton, M Blackburn, D Rankin, JM Allen, FM Campbell, L Leelarathna, ...","Diabetes technology & therapeutics 21 (3), 119-127",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11964383161880277745,4,2019
Hypoglycaemia incidence and recovery during home use of hybrid closed‐loop insulin delivery in adults with type 1 diabetes,"Y Ruan, L Bally, H Thabit, L Leelarathna, S Hartnell, M Tauschmann, ...","Diabetes, Obesity and Metabolism 20 (8), 2004-2008",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5188057681303014006,4,2018
Modelling the effect of insulin on the disposal of meal-attributable glucose in type 1 diabetes,"F García-García, R Hovorka, ME Wilinska, D Elleri, ME Hernando","Medical & biological engineering & computing 55 (2), 271-282",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15060011875026023008,4,2017
The future of the artificial pancreas,"H Thabit, R Hovorka","Diabetes technology & therapeutics 17 (11), 763-765",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11870616991283367527,4,2015
Factors associated with glycemic control during free-living overnight closed-loop insulin delivery in children and adults with type 1 diabetes,"M Tauschmann, H Thabit, L Leelarathna, D Elleri, JM Allen, ...","Journal of diabetes science and technology 9 (6), 1346-1347",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15883186618404087297,4,2015
Artificial pancreas: the bridge to a cure for type 1 diabetes,"H Thabit, R Hovorka, M Evans","European Diabetes Nursing 9 (2), 56-60",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6465180970680670272,4,2012
Comparison of two closed loop algorithms with open loop control in type 1 diabetes,"JH Devries, A Avogaro, C Benesch, D Bruttomesso, K Caldwell, C Cobelli, ...","Diabetes 61, A60-A60",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7385218468264988279,4,2012
Pilot study to evaluate blood glucose control by a model predictive control algorithm with variable sampling rate vs. routine glucose management protocol in peri-and …,"T Roubicek, J Kremen, J Blaha, M Matias, P Kopecký, J Rulisek, ...","Casopis lekaru ceskych 146 (11), 868-873",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16489024314026176870,4,2007
Modeling interstitial glucose kinetics in subjects with type I diabetes during physiological conditions,"ME Wilinska, H Schaller, L Schaupp, TR Pieber, LJ Chassin, R Hovorka",Proceedings of the Second Joint 24th Annual Conference and the Annual Fall …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14596362352001960143,4,2002
Simulating closed-loop glucose control: Effect of delay in glucose measurement,LJ Chassin,"Diabetes Suppl 2 51, A391, 1606-P",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4906610634006050839,4,2002
"35th Annual Meeting of the European Association for the Study of Diabetes: Brussels, Belgium, 28 September–2 October 1999","A Melander, J Olsson, G Lindberg, A Salzman, T Howard, P Stang, ...","Diabetologia 42, A1-A330","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3071330907396224640,15349700399002789878",4,1999
"Estimating protein turnover with a [13N, 15C] leucine tracer: a study using simulated data","IJ Gowrie, AV Roudsari, AM Umpleby, R Hovorka","Journal of theoretical biology 198 (2), 165-172",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1786894803637857519,4,1999
A dynamic model of carbon dioxide transport in the blood,"SE Rees, S Andreassen, R Hovorka, ER Carson","IFAC Proceedings Volumes 30 (2), 57-62",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16053712730027595495,4,1997
Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes,"M Tauschmann, R Hovorka","Expert opinion on drug delivery 14 (12), 1367-1377",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2052448399102908922,3,2017
Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes,"Y Ruan, H Thabit, L Leelarathna, S Hartnell, ME Wilinska, M Tauschmann, ...","Diabetes, Obesity and Metabolism 19 (10), 1485-1489",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2013190784218775885,3,2017
Glucose turnover after replacement of usual therapy by insulin in insulin-naive type 2 diabetes subjects,"H Thabit, K Kumareswaran, A Haidar, L Leelarathna, K Caldwell, D Elleri, ...","The Journal of Clinical Endocrinology & Metabolism 99 (6), 2225-2232",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17137980829563470719,3,2014
Time in hypoglycaemia in patients with type 1 diabetes is dramatically reduced when insulin infusion is driven by two closed-loop algorithms in a randomised clinical trial,"EM Renard, JH DeVries, R Hovorka, W Doll, L Heinemann, C Cobelli, ...","Diabetologia 55, S86-S86",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9374312578938271298,3,2012
Overnight closed-loop insulin delivery in patients with type 1 diabetes,"ME Wilinska, JM Allen, D Elleri, K Kumareswaran, M Nodale, ML Evans, ...",5th European Conference of the International Federation for Medical and …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8150830027479594676,3,2011
Overnight closed loop (CL) glucose control following consumption of alcohol in adults with type 1 diabetes (T1D),"K Kumareswaran, J Harris, D Elleri, JM Allen, M Nodale, J Weston, ...","Diabetes 59, A95-A95",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17411020093681524118,3,2010
Effect of delay on measurement of blood glucose levels in young subjects with type 1 diabetes,"D Elleri, CL Acerini, JM Allen, AMF Larsen, ME Wilinska, DB Dunger, ...","Diabetes research and clinical practice 86 (2), e31-e33",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14371127431194029331,3,2009
Overnight Closed-Loop (CL) Insulin Delivery in Children and Adolescents with Type 1 Diabetes (T1D): Towards Home Testing,"R Hovorka, CL Acerini, JM Allen, LJ Chassin, C Kollman, D Elleri, J Harris, ...","Diabetes 58, A54-A54",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17836289787020225412,3,2009
The use of continuous glucose monitoring combined with computer-based eMPC algorithm for tight glucose control in cardiosurgical ICU: a feasibility study,"M Mraz, P Kopecky, J Blaha, J Kremen, S Svacina, R Hovorka, M Haluzik","DIABETES 58, A55-A56",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14326169976073792229,3,2009
Glycemic Variability Strongly Correlates with Postprandial ß-cell Dysfunction in a Segment of Type 2 Diabetic Patients Using Oral Hypoglycemic Agents,"KD Kohnert, P Augstein, E Zander, P Heinke, K Peterson, EJ Freyse, ...",Diabetes Care,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12384894451188146163,3,2009
Simulating control of glucose concentration in subjects with type 1 diabetes: example of control system with inter-and intra-individual variations,"L Chassin, U Haueter, R Hovorka, M Massi-Benedetti, M Orsini Federici, ...",Proceedings of the EUNITE—2001 Symposium Chios: University of Aegean 68,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=561669455404027455,3,2001
Stochastic representation of the minimal model of glucose kinetics,"R Hovorka, S Luzio, DR Owens","DIABETES NUTRITION AND METABOLISM 11, 87-87",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=846946283249415547,3,1998
Implementation of interpatient variability and of dose size dependency of the absorption speed of NPH insulin in the Diabetes Advisory System (DIAS),"OK Hejlesen, S Andreassen, R Hovorka, DA Cavan",Symposium on Computers in Diabetes 11 (1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15907881224898952667,3,1998
Evaluation of a diabetes advisory system in adolescents,"OK Hejlesen, M Rix, S Andreassen, A Lange, J Schaarup, E Østergaard, ...",International Diabetes Federation Congress 40 (Suppl. 1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12149730040268357237,3,1997
Is the Somogyi effect due to reduced absorption of intermediate acting insulin following hypoglycaemia?,"OK Hejlesen, S Andreassen, R Hovorka, DR Meeking, DA Cavan",Autumn Meeting of the British Diabetic Association Medical & Scientific …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7876725134558343761,3,1996
Using the diabetes advisory system (DIAS) to provide patient specific advice on insulin dose to prevent hypoglycaemia,"DA Cavan, OK Hejlesen, R Hovorka, DR Meeking, S Andreassen, ...","Proceedings, Symposium on Computers in Diabetes, 31 August-1 September 1996 …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9921148814497734026,3,1996
Evaluation of Diabetes Advisory System (DIAS) by a double blind controlled clinical trial: a necessary step?,"S Andreassen, OK Hejlesen, NE Frandsen, T Petersen, SH Sandø, ...","Proceedings, Symposium on Computers in Diabetes, 31 August-1 September 1996 …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6743652930262255717,3,1996
Graphsearch A* algorithm in insulin therapy,"R Hovorka, Š Svačina, M Malík","Advances in Biomedical Measurement, 391-399",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17696856606672704721,3,1988
"Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in …","G Musolino, JM Allen, S Hartnell, ME Wilinska, M Tauschmann, ...","BMJ open 9 (6), e027856",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15174028129034298261,2,2019
Reduced burden of diabetes and improved quality of life: experiences from unrestricted day‐and‐night hybrid closed‐loop use in very young children with type 1 diabetes,"G Musolino, K Dovc, CK Boughton, M Tauschmann, JM Allen, K Nagl, ...",Pediatric diabetes,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14395075927663865968,2,2019
Closed‐loop insulin delivery in end‐of‐life care: a case report,"CK Boughton, L Bally, S Hartnell, M Wilinska, AP Coll, M Evans, C Stettler, ...",Diabetic Medicine,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8066343347057683143,2,2019
Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index,"L Leelarathna, H Thabit, ME Wilinska, L Bally, JK Mader, TR Pieber, ...","Journal of diabetes science and technology, 1932296819838525",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=158558328777600054,2,2019
Fully closed-loop insulin delivery to manage inpatient nutrition support on the general ward: A randomised controlled parallel design study,"C Boughton, L Bally, F Martignoni, S Hartnell, D Herzig, A Vogt, M Wertli, ...",The Lancet Publishing Group,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3112610833949723126,2,2019
Rapid benefits of structured optimization and sensor-augmented insulin pump therapy in adults with type 1 diabetes,"L Leelarathna, H Thabit, S Hartnell, ME Willinska, S Dellweg, C Benesch, ...","Journal of diabetes science and technology 11 (1), 180",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1573824723413464155,2,2017
Factors Affecting Recruitment of Participants for Studies of Diabetes Technology in Newly Diagnosed Youth with Type 1 Diabetes: A Qualitative Focus Group Study with Parents and …,"C Farrington, J Allen, M Tauschmann, T Randell, N Trevelyan, R Hovorka","Diabetes technology & therapeutics 18 (9), 568-573",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11382336360336270078,2,2016
Integrated closed-loop medication delivery with error model and safety check,"ME Wilinska, ES Budiman, GA Hayter, MB Taub, R Hovorka","US Patent 9,402,953",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4736680009730435545,2,2016
Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A Prospective Multi-center Pivotal Trial,"JH DeVries, J Kropff, P Choudhary, S Neupane, SC Bain, C Kapitza, ...","DIABETES TECHNOLOGY & THERAPEUTICS 18, A26-A26",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5373097679733495210,2,2016
"Validation of a closed loop system in paediatric patients, 6 to 12 years, with type 1 diabetes","U Schierloh, M Wilinska, H Thabit, B Tschapeller, C Krainer, M Witsch, ...","DIABETES TECHNOLOGY & THERAPEUTICS 17, A99-A100",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10545673452481493078,2,2015
Response to Mitre et al.:“Analysis of Continuous Glucose Monitoring Data to Assess Outpatient Closed-Loop Studies: Considerations for Different Sensors”,"R Hovorka, M Nodale","Diabetes technology & therapeutics 16 (5), 328-329",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8214399006317573871,2,2014
Continuous glucose monitoring in critically ill adults: comparison of two different calibration protocols,"L Leelarathna, S English, H Thabit, K Caldwell, J Allen, K Kumareswaran, ...","Critical Care 17 (2), P459",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8067560113464029851,2,2013
Closed-loop (CL) insulin delivery with reduced meal insulin bolus to minimize risk of postmeal hypoglycemia in adolescents with type 1 diabetes (T1D),"D Elleri, JM Allen, M Biagioni, K Kumareswaran, L Leelarathna, ...","Diabetes 61, A227-A227",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5095985909300978057,2,2012
Factors affecting performance of overnight closed-loop insulin delivery in type 1 diabetes (T1D),"M Nodale, D Elleri, JM Allen, K Kumare-Swaran, J Harris, A Haidar, ...","Diabetes 61, A58-A58",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12344289773570707549,2,2012
Glucose appearance of large evening meals with low and high glycaemic load in type 1 diabetes,"D Elleri, JM Allen, J Harris, A Haidar, K Kumareswaran, L Leelarathna, ...","Diabetologia 54, S54-S54",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1377345786799563650,2,2011
Glucose appearance of large slowly-absorbed evening meal containing complex carbohydrates (CHO) in type 1 diabetes (T1D),"D Elleri, J Harris, K Kumareswaran, JM Allen, A Haidar, M Nodale, ...",Diabetologia 53,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10697625976982273714,2,2010
The treatment of hyperglycaemia in critically ill patients: comparison of standard protocol and computer algorithm,"J Kremen, J Blaha, P Kopecký, L Bosanska, E Kotrlikova, T Roubicek, ...","Vnitrni lekarstvi 53 (12), 1269-1273",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2576570908621987167,2,2007
Comparison of different insulin protocols in post-cardiac surgery patients: multicentre European study: P-79,"J Blaha, R Hovorka, J Kremen, JJ Cordingley, S Squire, J Plank, ...","European Journal of Anaesthesiology (EJA) 23, 27-28",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5636750558530847067,2,2006
Hypoglycaemia reduces and insulin increases interstitial to plasma glucose ratio during physiological conditions in subjects with Type 1 diabetes,"ME Wilinska, H Schaller, L Schaupp, TR Pieber, LJ Chassin, R Hovorka","Diabetologia 45, A311-A311",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15088069201286344675,2,2002
Assessing the effect of delay in glucose sampling on closed-loop glucose control: a simulation study: P166,"L Chassin, M Wilinska, R Hovorka",Diabetic Medicine Supplement 19,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17613311800787896106,2,2002
Pancreatic β-Cell Responsiveness Is Reproducible in Type 2 Diabetes during MTT,"A ALBARRAK, S LUZIO, R PLAYLE, R HOVORKA, D OWENS",Diabetes 50,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13464010444558338581,2,2001
Model predictive control: using non-linear model to control glucose excursions in subjects with type 1 diabetes,"R Hovorka, LJ Chassin",Adaptive systems and hybrid computational intelligence in medicine. Greece …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7537969821884620749,2,2001
A surrogate measure of whole body leucine transport across the cell membrane,"R Hovorka, PV Carroll, IJ Gowrie, NC Jackson, DL Russell-Jones, ...","American Journal of Physiology-Endocrinology and Metabolism 276 (3), E573-E579",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14079134236846856619,2,1999
IGF-I but not an IGF-I analog increases serum IGF binding protein-3 (IGFBP-3) in adolescent female monkeys,ME Wilson,"Growth Hormone & IGF Research 4 (8), 315",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14683008555062253963,2,1998
A model of endogenous glucose balance incorporating the known characteristics of glucose transporters,"T Arleth, S Andreassen, OK Hejlesen, D Cavan, R Hovorka",Symposium on Computers in Diabetes 11 (1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14614651826666727315,2,1998
A retrospective pilot peer assessment of insulin advisory system for patients with type 2 diabetes,"RS Tudor, R Hovorka, DA Cavan, D Meeking, B Turner","DIABETES NUTRITION AND METABOLISM 11, 75-75",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6348288836747412438,2,1998
""" Insulin effectiveness"" determined by the DIAS model is related to dietary composition and glycaemic control","B Turner, E Jenkins, O Hejlesen, S Andreassen, R Hovorka, D Kerr, ...","DIABETES NUTRITION AND METABOLISM 11, 79-79",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3227243643193184418,2,1998
Using a diabetes advisory system to evaluate a patient-led system of semi-quantitative dietary assessment,"DR Meeking, OK Hejlesen, J Metcalfe, S Andreassen, R Hovorka, ...","Studies in Health Technology and Informatics, 521-527",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14193832847950084563,2,1996
Insulin doses and carbohydrate intake in IDDM patients performing exercise,"T Arleth, S Andreassen, AG Kjaer, OK Hejlesen, DR Meeking, DA Cavan, ...","Proceedings, Symposium on Computers in Diabetes, 31 August-1 September 1996 …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10095677452169704019,2,1996
A positive correlation between the total daily dosage of intermediate acting insulin and the magnitude of hypoglycaemic counter-regulations in insulin dependent diabetes …,"OK Hejlesen, S Andreassen, R Hovorka, DA Cavan","Proceedings, Symposium on Computers in Diabetes, 31 August-1 September 1996 …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4728515451592700671,2,1996
REPRODUCIBILITY OF INSULIN SENSITIVITY INDEXES FROM STABLE-LABEL EUGLYCEMIC GLUCOSE CLAMP STUDIES,"R Hovorka, J Patel, ZV Williams, F Pirjamali, MA Young, DJA Eckland","Diabetologia 38, A127-A127",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8721754869673236269,2,1995
REPRODUCIBILITY OF PREHEPATIC INSULIN-SECRETION DURING IVGTT,"R Hovorka, J Patel, S Lettis, R Pirjamali, MA Young, DJA Eckland","Diabetologia 37, A126-A126",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17622573797473098991,2,1994
A simulation study to determine optimal insulin priming during glucose clamp studies,"R Hovorka, JK Powrie, RH Jones","Computer methods and programs in biomedicine 41 (3-4), 231-241",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14173843781942560043,2,1994
The DIAS computer model accurately predicts unrecognised hypoglycaemia in patients with insulin-dependent diabetes,"DA Cavan, R Hovorka, S Andreassen, ER Carson, PH Sönksen",Symposium on Computers in Diabetes on the occasion of EASD 94 11 (Suppl. 2),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14748206940087447226,2,1994
A causal probabilistic network model of carbohydrate metabolism for insulin therapy adjustment,"S Andreassen, J Benn, E Carson, R Hovorka, U Kjacerulff, KG Olesen",[1990] Proceedings of the Twelfth Annual International Conference of the …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16756364626527054763,2,1990
Strategies for insulin dosage adjustment using model-based blood glucose prediction,"R Hovorka, ER Carson, S Svacina",[1990] Proceedings of the Twelfth Annual International Conference of the …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14314406506428888241,2,1990
Experience with a computer database in a cytogenetic laboratory,"J Musilova, R Hovorka, Z Zemanova, K Michalova, S Svacina","Casopis lekaru ceskych 129 (24), 742-744",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4103604455263626450,2,1990
A causal probabilistic network model of carbohydrate metabolism in diabetes,"S Andreassen, J Benn, E Carson, LD Kristensen, R Hovorka, UB Kjærulff, ...",Proceedings of the 8th Nordic Meeting on Medical and Biological Engineering …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9438813677446678641,2,1990
Analysis of glycosylated serum protein changes using a computer model.,"S Svacina, R Hovorka, J Skrha, Z Masek","Czechoslovak medicine 13 (4), 168-174",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4598404925647168766,2,1990
A causal probabilistic network model to assist in insulin therapy adjustment,"R Hovorka, S Andreassen, JJ Benn, ER Carson, UB Kjærulff, ...","Proceedings of the 6th Annual Meeting on Expert Systems in Medicine, 1990 …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16957121660499309768,2,1990
A computer model of hemoglobin glycosylation,"S Svacina, R Hovorka, A Hodinár","Sbornik lekarsky 89 (5), 134",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16014265101202007484,2,1987
Short‐term fully closed‐loop insulin delivery using faster insulin aspart compared to standard insulin aspart in type 2 diabetes,"L Bally, D Herzig, Y Ruan, ME Wilinska, M Semmo, A Vogt, MM Wertli, ...","Diabetes, Obesity and Metabolism",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=335545448717765139,1,2019
The importance of prandial insulin bolus timing with hybrid closed‐loop systems,"CK Boughton, S Hartnell, JM Allen, R Hovorka",Diabetic Medicine,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10928890082089022142,1,2019
Novel Single-Site Device for Conjoined Glucose Sensing and Insulin Infusion: Performance Evaluation in Diabetes Patients During Home-Use,"M Tschaikner, K Powell, M Jungklaus, M Fritz, M Ellmerer, R Hovorka, ...",IEEE Transactions on Biomedical Engineering,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=507707068330398395,1,2019
Glucose Management Indicator (GMI): Insights and Validation Using Guardian 3 and Navigator 2 Sensor Data,"L Leelarathna, RW Beck, RM Bergenstal, H Thabit, R Hovorka","Diabetes care 42 (4), e60-e61",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5032742592616767991,1,2019
Diabetes Technology and Therapy in the Pediatric Age Group,"DM Maahs, R Lal, S Shalitin","Diabetes technology & therapeutics 21 (S1), S-123-S-137",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6331091736479982454,1,2019
Women’s experiences of day-and-night closed-loop insulin delivery during Type 1 diabetes pregnancy,"C Farrington, Z Stewart, R Hovorka, H Murphy","Journal of diabetes science and technology 12 (6), 1125-1131",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10161801343600617796,1,2018
Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance,"MB Whyte, F Shojaee-Moradie, SE Sharaf, NC Jackson, B Fielding, ...","The Journal of Clinical Endocrinology & Metabolism 104 (2), 359-368",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15032525114151175712,1,2018
Day-and-night closed-loop in a broad population of pregnant women with type 1 diabetes: a randomized controlled crossover trial,"ZA Stewart, ME Wilinska, S Hartnell, LK O’Neil, G Rayman, EM Scott, ...",Diabetes Care 41 (4),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12593077373380500141,1,2018
Sensor Life and Overnight Closed Loop: A Randomized Clinical Trial,"M Tauschmann, JM Allen, ME Wilinska, Y Ruan, H Thabit, CL Acerini, ...","Journal of diabetes science and technology 11 (3), 513-521",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15514058013874206086,1,2017
Glucose Monitoring and Insulin Pump Therapy in the Management of Children and Adolescents with Type 1 Diabetes,"M Tauschmann, R Hovorka","Research into Childhood-Onset Diabetes, 163-172",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5284200387244451171,1,2017
"Automated Artificial Pancreas System in Type 2 Diabetes in the General Ward: A Randomized, Controlled, Parallel-Design Study","H Thabit, S Hartnell, JM Allen, A Lake, E Malgor-Zata, ML Evans, AP Coll, ...","DIABETES 65, A22-A22",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2341560443758485079,1,2016
Miniaturization of the artificial Pancreas by Merging of Insulin Administration and Glucose Measurement in the subcutaneous Adipose Tissue,"M Tschaikner, K Powell, M Jungklaus, M Fritz, M Ellmerer, R Hovorka, ...","WIENER KLINISCHE WOCHENSCHRIFT 127, S146-S147",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4067399072385248619,1,2015
Substance monitoring and control in human or animal bodies,R Hovorka,"US Patent App. 14/615,247",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12056777321015884075,1,2015
A diet low in sugar reduces the production of atherogenic lipoproteins in men with high liver fat,"M Umpleby, F Shojaee-Moradie, B Fielding, X Li, C Isherwood, N Jackson, ...","Atherosclerosis 241 (1), e46",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6819871707222970062,1,2015
Glucose control in the ICU using continuous glucose monitoring: What level of the measurement error is acceptable?,"ME Wilinska, R Hovorka",American Association for Clinical Chemistry,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15603571243383745131,1,2014
Overnight closed-loop insulin delivery: psychosocial impact for adults with type 1 diabetes,"K Barnard, H Thabit, A Lubina-Solomon, M Stadler, E Walkinshaw, A Iqbal, ...","Diabetes 63, A198-A198",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6870228744357158912,1,2014
PSYCHOSOCIAL IMPACT OF CLOSED LOOP THERAPY-ADULTS WITH TYPE 1 DIABETES: OVERNIGHT CLOSED LOOP AT HOME STUDY,"KD Barnard, H Thabit, E Walkinshaw, A Lubina-Solomon, M Stadler, ...","DIABETES TECHNOLOGY & THERAPEUTICS 16, A102-A102",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7825523357250910591,1,2014
Efficacy and safety of reduced prandial boluses during closed-loop insulin delivery in adolescents with type 1 diabetes,"D Elleri, JM Allen, M Biagioni, K Kumareswaran, L Leelarathna, ...","DIABETOLOGIA 55, S86-S87",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15553809218786905217,1,2012
"Pharmacokinetics of Insulin Aspart in Pump-Treated Type 1 Diabetes (T1D): Reproducibility and Effect of Age, Weight, and Duration of Diabetes","A Haidar, D Elleri, J Allen, K Kumareswaran, J Harris, L Leelarathna, ...","Diabetes 61, A231-A232",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=250431807262493152,1,2012
Physical activity energy expenditure and glucose levels in pregnant women with type 1 diabetes during free-living and controlled conditions,"K Kumareswaran, S Brage, K Westgate, D Elleri, J Allen, M Nodale, ...","Diabetes 61, A341-A342",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17837549448998942511,1,2012
Continuous glucose monitoring performance during exercise in pregnant women with type 1 diabetes,"K Kumareswaran, D Elleri, J Allen, K Caldwell, D Simmons, M Nodale, ...","Diabetes 61, A219-A219",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17771214625366765371,1,2012
The use of continuous glucose monitoring (CGM) to evaluate performance of closed-loop insulin delivery systems,"M Nodale, A Haidar, ME Wilinska, R Hovorka","Diabetes 60, A64-A64",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15625081908346623869,1,2011
Changes in Glucose Turnover and during Pregnancy in Women with Type 1 Diabetes,"HR Murphy, D Elleri, JM Allen, J Harris, D Simmons, G Rayman, ...","Diabetes 60, A54-A54",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=821884688739387690,1,2011
Closed loop insulin delivery protects against nocturnal hypoglycaemia after moderate physical activity in pregnant women with type 1 diabetes,"H Murphy, K Kumareswaran, J Allen, D Elleri, P Raymond-Barker, ...",Diabetic Medicine 28,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15595476656862897426,1,2011
Triple tracer (TT) and double tracer (DT) techniques are reliable methods to estimate glucose appearance in type 1 diabetes,"A Haidar, D Elleri, JM Allen, J Harris, K Kumareswaran, M Nodale, ...",Diabetologia 53,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3324829287458217025,1,2010
Closed loop glycaemic control during pregnancy in women with type 1 diabetes: a proof of concept pilot study,"H Murphy, J Allen, D Elleri, J Harris, D Simmons, G Rayman, R Temple, ...",Diabetic Medicine 27,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1354204979064854668,1,2010
Evaluation of a model predictive control algorithm using time-variant sampling to establish tight glycaemic control in clinical practice,"C Pachler, J Plank, H Weinhandl, R Hovorka, L Chassin, P Kaufmann, ...","Critical Care 11 (2), P138",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11815478257007819256,1,2007
Effect of nutritional protocol and measurement error on automated glucose control in the ICU,"ME Wilinska, LJ Chassin, R Hovorka","Diabetologia 49, 587-588",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3671712663832603756,1,2006
"Pancreas, artificial",R Hovorka,Encyclopedia of Medical Devices and Instrumentation,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1741991586467707345,1,2006
Time-variant insulin sensitivity in critically ill subjects,"FR Wink, ME Wilinska, LJ Chassin, M Haluzik, J Blaha, S Svacina, ...","IFAC Proceedings Volumes 39 (1), 458-462",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11515243056035507026,1,2006
Mass kinetics of apolipoprotein A-1 in interstitial fluid after intravenous infusion of reconstituted high-density lipoproteins in humans: Implications for therapeutic regimens,"MN Nanjee, R Hovorka, CJ Cooke, WL Olszewski, ER Carson, IP Miller, ...","CIRCULATION 112 (17), U293-U294",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9423870612075836965,1,2005
"Comparison of insulin sensitivity using MINMOD, HOMA, and QUICKI in type 2 diabetes","T Hovorka, O Agbaje, SD Luzio, DR Owens, R Hovorka","Diabetes 54, A620",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=577064504867184532,1,2005
Good glucose control at surgical ICU with model predictive controller and hourly sampling,"R Hovorka, J Cordingley, ME Wilinska, S Squire","Diabetes 54, A106",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16465824613480641160,1,2005
Assessment of insulin resistance during cardiac surgery,"M WILINSKA, G Harrison, F Shojaee-Moradie, R HOVORKA, C MORGAN",Diabetic Medicine 22,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7897753701546236415,1,2005
Randomized controlled study for the evaluation of automated blood glucose control in critically ill patients,"J Plank, M Ellmerer, W Toller, B Rigler, A Amegah-Sakotnik, R Hovorka, ...","Critical Care 9 (1), P386",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16624461561507443930,1,2005
Evaluation of cold two compartment minimal model in type 2 diabetes,"AIS Albarrak, SD Luzio, DR Owens, R Hovorka","IFAC Proceedings Volumes 36 (15), 445-450",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=194304004677607722,1,2003
Reduced sampling protocols with Bayesian hierarchical analysis during minimal model of IVGTT,"OF Agbaje, SD Luzio, AIS Albarrak, DJ Lunn, DR Owens, R Hovorka","IFAC Proceedings Volumes 36 (15), 421-425",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12423136624749682482,1,2003
Automated subcutaneous insulin infusion driven by subcutaneous glucose measurements presents clinically acceptable control over a 24-h study,"L Chassin, M Wilinska, R Hovorka",Diabetic Medicine Supplement 20,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3055400145049758683,1,2003
Full phase insulin response is more closely associated with deteriorated glucose control than first phase insulin response in newly presenting Type 2 diabetes,"A Albarrak, SD Luzio, R Hovorka, DR Owens","Diabetologia 45, A144-A144",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9320381416493914758,1,2002
Relationship between interstitial and plasma glucose during physiological conditions: P174,"M Wilinska, H Schaller, L Schaupp, T Pieber, L Chassin, R Hovorka",Diabetic Medicine Supplement 19,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10397469952104199145,1,2002
Pancreatic [beta]-cell responsiveness during MTT and OGTT in Type 2 diabetes subjects,"A Albarrak, S Luzio, R Hovorka, D Owens",Diabetic Medicine Supplement 19,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4466289463559919069,1,2002
Population approach to estimate insulin sensitivity and glucose effectiveness by minimal model,"S Agbaje, R Playle, SD Luzio, AIS Albarrak, DJ Lunn, DR Owens, ...","Diabetologia 44, A55-A55",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14239683560353036291,1,2001
"Partitioning glucose Transport/Distribution, disposal. and endogenous production during IVGTT","F Shojaee-Moradie, PV Carroll, LJ Chassin, IJ Gowrie, NC Jackson, ...","Diabetes 50, A281-A282",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17218844683888128055,1,2001
Reproducibility and Comparability of Pancreatic β-cell Responsiveness during MTT and OGTT in Healthy Subjects,"A ALBARRAK, S LUZIO, R Playle, R HOVORKA, D OWENS",Diabetic Medicine Supplement 18,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7370460722910109369,1,2001
Deconvolution and credible intervals using Markov chain Monte Carlo method,R Hovorka,"International Symposium on Medical Data Analysis, 111-121",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5031715785628550744,1,2000
"Relationships between clinical measures of diabetes control, and insulin sensitivity and pancreatic reponsiveness in newly presenting type 2 diabetes","DR OWENS, AIS ALBARRAK, S D LUZIO, LJ CHASSIN, R PLAYLE, ...","Diabetes 48 (5), SA297-SA297",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16927394479085469250,1,1999
Troglitazone does not modify C-peptide kinetics in patients with diet-treated type 2 diabetes,"M MULCAHY, S D LUZIO, EA FOOT, LJ CHASSIN, MA YOUNG, ...","Diabetes 48 (5), SA357-SA357",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1656445179468436026,1,1999
"Type of meal, breakfast vs dinner, affects pancreatic responsiveness in healthy non-obese subjects","LJ CHASSIN, MA YOUNG, R HOVORKA","Diabetes 48 (5), SA296-SA296",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4043905687067275876,1,1999
The DIAS computer model uncovers frequent insulin,"BC Turner, E Jenkins, OK Hejlesen, S Andreassen, R Hovorka, D Kerr, ...",Diabetologia 42 (Suppl. 1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6243686121777907068,1,1999
A model-based approach to the Somogyi phenomenon: a study of the 32 hour hormonal response to spontaneous nocturnal hypoglycaemia,"KD Jensen, OK Hejlesen, HH Lervang, S Andreassen, R Hovorka, ...",Symposium on Computers in Diabetes 11 (1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7974008858491584421,1,1998
Insulin sensitivity and pancreatic beta-cell responsiveness in newly diagnosed non insulin dependent diabetics,"L Chassin, SD Luzio, R Hovorka, DR Owens","Diabetologia 40, 1129-1129",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14871488099711955985,1,1997
Positive attitudes amongst patients and nurses towards' DIAS'-A tool for providing insulin dose advice,"DR Meeking, S Cradock, J Dowell, R Hovorka, DA Cavan","Diabetologia 40, 1317-1317",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1938346422049396737,1,1997
Quantification of pancreatic responsiveness during a standardised meal tolerance test,"R Hovorka, L Chassin, SD Luzio, DR Owens","Diabetologia 40, 376-376",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15866667277879453340,1,1997
Measuring insulin secretion: Accuracy and effect of sampling schedule,"R Hovorka, E Koukkou, D Southerden, JK Powrie, MA Young","Diabetologia 40, 380-380",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9701265119852731218,1,1997
Extracellular and intracellular glucose under basal conditions in man,"F ShojaeeMoradie, DA Cavan, H DeLaPaz, R Hovorka, S Imuere, ...","Diabetologia 40, 987-987",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7727371736049630054,1,1997
Comparison of B-cell responsiveness measured by intravenous glucose and meal tolerance tests.,"S Luzio, J Makhlouf, L Chassin, R Hovorka, D Owens","Diabetes 46, 1367-1367",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12255950618669445547,1,1997
Daily rhIGF-I augments the anabolic effect of insulin in adults with IDDM.,"P Carroll, E Christ, I Gowrie, N Jackson, R Hovorka, E Albany, S Bowes, ...","Diabetes 46, 945-945",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12636605273323627594,1,1997
Estimating relative input function from response function,R Hovorka,"IFAC Proceedings Volumes 30 (2), 265-270",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4727117035802765113,1,1997
Evaluation of a diabetes advisory system,"S Andreassen, OK Hejlesen, NE Frandsen, T Petersen, SH Sandø, ...",International Diabetes Federation Congress 40 (Suppl. 1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15211475432871160331,1,1997
Computer simulation in clinical practice,"S Svacina, T Haas, R Hovorka","International Journal of Medical Informatics 1 (45), 129-130",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9339615915956602207,1,1997
A positive correlation between the magnitude of the Somogyi effect and the dosage of intermediate acting insulin,"OK Hejlesen, S Andreassen, R Hovorka, D Meeking, DA Cavan",International Diabetes Federation Congress 40 (Suppl. 1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3030180440630561638,1,1997
REPRODUCIBILITY OF PARAMETER ESTIMATES FROM THE 2 COMPARTMENT MINIMAL MODEL OF LABELED IVGTT,"D Murley, R Hovorka, MA YOUNG, J PATEL","Diabetologia 38, A128-A128",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15215178619339748603,1,1995
The Diabetes Advisory System: a new tool for management of patients with hypoglycaemia?,"DA Cavan, OK Hejlesen, R Hovorka, JA Metcalf, MR Cavan, ...",Diabetic Medicine 12 (Suppl. 2),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6210006974203820562,1,1995
Are insulin-dependent diabetic patients receiving too much insulin?,"DA Cavan, OK Hejlesen, R Hovorka, S Andreassen, ER Carson, ...",Diabetic Medicine 12 (Suppl. 1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17478799474968668719,1,1995
Retrospective testing of an insulin advisory system.,"S Svacina, T Haas, R Hovorka","Sbornik lekarsky 96 (4), 307-312",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14288400671277538267,1,1995
A non-linear model of insulin kinetics,"R Hovorka, JK Powrie, GD Smith, ER Carson, PH Sonksen, RH Jones","Medical Informatics Europe 1991, 597-601",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7770566009278759131,1,1991
Ten Years of Computer Support in a Metabolic Intensive Care Unit,"S Svacina, R Hovorka, T Haas, Z Masek, J Kabrt","Medical Informatics Europe 1991, 930-933",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5359041695290741169,1,1991
A consulting system for insulin therapy in diabetes,"R Hovorka, S Svacina, Z Masek, J Páv","Casopis lekaru ceskych 129 (14), 417-423",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15973924863948943114,1,1990
Analysis of dynamic changes in glycosylated blood proteins using a computer model,"S Svacina, R Hovorka, J Skrha, Z Masek","Casopis lekaru ceskych 129 (7), 204-207",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3167000556149285475,1,1990
A causal probabilistic network model of carbohydrate metabolism for insulin adjustment,"S Andreassen, JJ Benn, E Carson, R Hovorka, UB Kjærulff, KG Olesen",Biomedical Engineering Perspectives: Health Care Technologies for the 1990 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15215286535270741177,1,1990
Use of a causal probabilistic network for insulin dose adjustment in diabetes,"J Benn, S Andreassen, ER Carson, LD Kristensen, R Hovorka, ...",Proceedings of the International Symposium Held on the Occasion of the …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14313497276121332085,1,1990
Mathematical models of insulin receptor binding: a comparative study,"R Hovorka, J Hilgertova, ER Carson","Clinical Science 78 (s22), 14P-14P",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14757996236791362968,1,1990
The effect of compensation in diabetes mellitus on energy metabolism in conventionally treated insulin-dependent diabetics,"J Kábrt, J Páv, Z Masek, S Svacina, R Hovorka","Casopis lekaru ceskych 127 (17), 531",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1118624246745694370,1,1988
The effect of continuous subcutaneous administration of insulin on the oxidation of energy substrates in insulin-dependent diabetics,"J Kábrt, J Páv, Z Masek, S Svacina, R Hovorka","Casopis lekaru ceskych 127 (18), 549-552",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17656048433338541846,1,1988
The insulin pump in type II diabetics,"S Svacina, Z Masek, J Páv, J Kábrt, R Hovorka, J Ponka","Vnitrni lekarstvi 34 (2), 146",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17138031105990031656,1,1988
Personal experience with the stabilized blood glucose test (blood glucose clamp),"S Svacina, J Skrha, J Páv, R Hovorka","Vnitrni lekarstvi 34 (2), 138",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12534677919843227681,1,1988
Computers in internal medicine,"S Svacina, M Malik, V Pacovský, R Hovorka","Vnitrni lekarstvi 33 (5), 480",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13953124488995583560,1,1987
Processing indeterminate data in medicine,"R Hovorka, S Svacina","Casopis lekaru ceskych 126 (11), 321",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4402775802854589857,1,1987
Structure of an expert system for insulin therapy,"S Svacina, R Hovorka","Vnitrni lekarstvi 32 (10), 994",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3472544436490958909,1,1986
Health professionals’ views about who would benefit from using a closed-loop system: qualitative study,"J Lawton, B Kimbell, D Rankin, NL Ashcroft, L Varghese, JM Allen, ...",Wiley-Blackwell,,0,2019
Automated Insulin Delivery in Adults,"CK Boughton, R Hovorka",Endocrinology and Metabolism Clinics,,0,2019
A Qualitative Study of Clinician Attitudes Towards Closed-Loop Systems in Mainstream Diabetes Care in England,"C Farrington, HR Murphy, R Hovorka",Wiley-Blackwell,,0,2019
Closed-loop management of inpatient hyperglycaemia,"CK Boughton, R Hovorka","British Journal of Hospital Medicine 80 (11), 665-669",,0,2019
A randomised crossover trial evaluating fully closed-loop with faster vs standard aspart in type 2 diabetes,"L Bally, D Herzig, Y Ruan, M Wilinska, M Semmo, A Vogt, M Wertli, B Vogt, ...","DIABETOLOGIA 62, S384-S385",,0,2019
Closed-loop management of inpatient hyperglycemia,"CK Boughton, L Bally, R Hovorka","Aging (Albany NY) 11 (15), 5292",,0,2019
Feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants,"K Beardsall, L Thomson, D Elleri, DB Dunger, R Hovorka","Archives of Disease in Childhood-Fetal and Neonatal Edition, fetalneonatal …",,0,2019
1046-P: Day-to-Day Variability of Insulin Requirements in Inpatients on General Wards,"CK BOUGHTON, LIA BALLY, H THABIT, S HARTNELL, D HERZIG, ...","Diabetes 68 (Supplement 1), 1046-P",,0,2019
79-OR: Fully Closed-Loop Using Faster vs. Standard Aspart in Type 2 Diabetes (T2D): A Double-Blind Randomised Crossover Trial,"LIA BALLY, D HERZIG, ME WILINSKA, YUE RUAN, A VOGT, MM WERTLI, ...","Diabetes 68 (Supplement 1), 79-OR",,0,2019
1039-P: Hybrid Closed-Loop in Adults with Type 1 Diabetes: Impact of Baseline A1c on Glucose Outcomes and Insulin Delivery,"L LEELARATHNA, H THABIT, ME WILINSKA, LIA BALLY, JK MADER, ...","Diabetes 68 (Supplement 1), 1039-P",,0,2019
115-LB: Optimal Sampling Duration of Hybrid Closed-Loop Therapy to Determine Long-Term Glycemic Control in Adults with Type 1 Diabetes,"L LEELARATHNA, H THABIT, ME WILINSKA, LIA BALLY, JK MADER, ...","Diabetes 68 (Supplement 1), 115-LB",,0,2019
1047-P: Can Closed-Loop Overcome High Day-to-Day Variability of Insulin Needs in Inpatients on General Wards?,"CK BOUGHTON, LIA BALLY, H THABIT, S HARTNELL, D HERZIG, ...","Diabetes 68 (Supplement 1), 1047-P",,0,2019
Integrated closed-loop medication delivery with error model and safety check,"ME Wilinska, ES Budiman, GA Hayter, MB Taub, R Hovorka","US Patent App. 16/251,572",,0,2019
Mixed‐meal tolerance test to assess residual beta‐cell secretion: Beyond the area‐under‐curve of plasma C‐peptide concentration,"Y Ruan, RH Willemsen, ME Wilinska, M Tauschmann, DB Dunger, ...","Pediatric diabetes 20 (3), 282-285",,0,2019
Broadening the debate about post-trial access to medical interventions: a qualitative study of participant experiences at the end of a trial investigating a medical device to …,"J Lawton, M Blackburn, D Rankin, C Werner, C Farrington, R Hovorka, ...","AJOB empirical bioethics 10 (2), 100-112",,0,2019
Improving glucose control in inpatients with type 2 diabetes on haemodialysis: The role of fully closed-loop insulin delivery,"L Bally, P Gubler, H Thabit, S Hartnell, Y Ruan, M Wilinska, M Evans, ...",Elsevier Inc.,,0,2019
Lower plasma insulin levels during overnight closed-loop in school children with type 1 diabetes: Potential advantage? A randomized cross-over trial,"U Schierloh, ME Wilinska, IM Pit-ten Cate, P Baumann, R Hovorka, ...","PloS one 14 (3), e0212013",,0,2019
COULD CLOSED-LOOP INSULIN DELIVERY BENEFIT INDIVIDUALS APPROACHING THE END OF LIFE? A CASE REPORT,"C Boughton, L Bally, S Hartnell, M Wilinska, A Coll, M Evans, C Stettler, ...","DIABETES TECHNOLOGY & THERAPEUTICS 21, A54-A54",,0,2019
CLOSED-LOOP INSULIN DELIVERY TO MANAGE INPATIENT NUTRITIONAL SUPPORT: A RANDOMISED CONTROLLED TRIAL,"C Boughton, L Bally, F Martignoni, S Hartnell, D Herzig, A Vogt, ...","DIABETES TECHNOLOGY & THERAPEUTICS 21, A54-A54",,0,2019
Case Report Closed-loop insulin delivery in end-of-life care: a case report,"CK Boughton, L Bally, S Hartnell, M Wilinska, AP Coll, M Evans, C Stettler, ...",,,0,2019
Use of the artificial Pancreas in Infants with Diabetes mellitus Type 1 KidsAP01,"H Kojzar, E Froehlich-Reiterer, JK Mader, T Poettler, H Elsayed, ...","WIENER KLINISCHE WOCHENSCHRIFT 130, 347-348",,0,2018
Fully closed-loop glucose control in haemodialysis patients with type 2 diabetes,"L Bally, H Thabit, S Hartnell, E Andereggen, Y Ruan, ME Wilinska, ...","DIABETOLOGIA 61, S396-S396",,0,2018
"Fully Closed-Loop Glucose Control in Noncritical Care Settings—A Randomised, Controlled Two-Centre Study","L Bally, H Thabit, S Hartnell, E Andereggen, Y Ruan, ME Wilinska, ...","Diabetes 67 (Supplement 1), 350-OR",,0,2018
"Adaptability of Closed-Loop during Labor, Delivery, and Postpartum—A Secondary Analysis of Data From Two Randomized Crossover Trials in Type 1 Diabetes Pregnancy","JM Yamamoto, ZA Stewart, ME Wilinska, S Hartnell, R Hovorka, ...","Diabetes 67 (Supplement 1), 1432-P",,0,2018
Looking Beyond HbA1c—Evaluating Glycaemic Control during Closed-Loop Use in Type 1 Diabetes,"H Thabit, L Leelarathna, ME Wilinska, C Benesch, S Arnolds, JK Mader, ...","Diabetes 67 (Supplement 1), 973-P",,0,2018
A Novel Composite Glucose Index (COGI) for Evaluating Closed-Loop Performance in Type 1 Diabetes,"L Leelarathna, H Thabit, L Bally, ME Wilinska, JK Mader, TR Pieber, ...","Diabetes 67 (Supplement 1), 926-P",,0,2018
KIDSAP-HOME USE OF THE ARTIFICIAL PANCREAS IN VERY YOUNG CHILDREN WITH TYPE 1 DIABETES: THE PILOT STUDY,"M Tauschmann, J Allen, S Slegtenhorst, N Barber, ME Wilinska, Y Ruan, ...","DIABETES TECHNOLOGY & THERAPEUTICS 20, A37-A37",,0,2018
HYPOGLYCAEMIA OCCURENCE AND RECOVERY DURING HOME USE OF CLOSED-LOOP INSULIN DELIVERY AND SENSOR-AUGMENTED PUMP THERAPY IN ADULTS WITH TYPE 1 DIABETES,"Y Ruan, L Bally, H Thabit, J Mader, H Kojzar, S Dellweg, C Benesch, ...","DIABETES TECHNOLOGY & THERAPEUTICS 20, A59-A60",,0,2018
CLOSED-LOOP FROM ONSET IN CHILDHOOD TYPE-1 DIABETES (CLOUD): A RANDOMISED CONTROLLED TRIAL TO ASSESS THE EFFECT OF CLOSED-LOOP INSULIN DELIVERY ON RESIDUAL BETA-CELL FUNCTION,"M Tauschmann, J Allen, S Slegtenhorst, ME Wilinska, N Barber, A Thorpe, ...","DIABETES TECHNOLOGY & THERAPEUTICS 20, A61-A62",,0,2018
OVERTREATMENT OF HYPOGLYCAEMIA IN ADULTS WITH TYPE 1 DIABETES DOES NOT APPEAR TO DETERIORATE GLYCAEMIC CONTROL DURING CLOSED-LOOP INSULIN DELIVERY,"Y Ruan, L Bally, H Thabit, JK Mader, H Kojzar, S Dellweg, C Benesch, ...","DIABETES TECHNOLOGY & THERAPEUTICS 20, A62-A63",,0,2018
CAN AN AUTOMATED CLOSED LOOP SYSTEM IMPROVE OUTCOME IN ADOLESCENTS WITH POORLY CONTROLLED TYPE 1 DIABETES? THE SPIDIMAN 02 STUDY,"U Schierloh, G AGUAYO, M Fichelle, D SCHAEFFER, A CELEBIC, ...","DIABETES TECHNOLOGY & THERAPEUTICS 20, A60-A60",,0,2018
The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference ,"T Danne, H De Vries, FJ Doyle, E Dassau, H De Vries, B Kovatchev, ...","Diabetes Technology & Therapeutics 20 (S1), A-1-A-152",,0,2018
Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care,"E Andereggen, Y Ruan, ME Wilinska, ML Evans, MM Wertli, AP Coll, ...",,,0,2018
Feasibility of automated insulin delivery guided by continuous glucose monitoring in extremely preterm infants,"K Beardsall, L Thomson, D Elleri, D Dunger, R Hovorka","bioRxiv, 374801",,0,2018
KidsAP-The artificial pancreas in children aged 1 to 7 years with type 1 diabetes,"H Kojzar, E Froehlich-Reiterer, J Mader, S Hofer, B Rami-Merhar, ...","WIENER KLINISCHE WOCHENSCHRIFT 129, 162-162",,0,2017
"Cover Image, Volume 19, Issue 10","Y Ruan, H Thabit, L Leelarathna, S Hartnell, ME Wilinska, M Tauschmann, ...","Diabetes, Obesity and Metabolism 19 (10), i-i",,0,2017
Determining duration of closed-loop studies: evidence from a randomised day-and-night three month trial,"L Leelarathna, H Thabit, ME Willinska, S Dellweg, JK Mader, S Hartnell, ...","DIABETOLOGIA 60, S324-S325",,0,2017
Sensor mightier than pump—the jury is still out,R Hovorka,"The Lancet Diabetes & Endocrinology 5 (9), 672-673",,0,2017
Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes,"R Hovorka, M Tauschmann",Taylor & Francis,,0,2017
Factors Affecting Performance of Fully Closed-Loop Insulin Delivery in Non-Critical-Care Inpatient Hyperglycaemia,"L Bally, H Thabit, S Hartnell, ME Wilinska, Y Ruan, A Lake, S Farnham, ...","DIABETES 66, A276-A276",,0,2017
Artificial Pancreas in an Acute General Hospital: A Randomised Controlled Study,"H Thabit, L Bally, S Hartnell, ME Wilinska, Y Ruan, A Lake, S Farnham, ...","DIABETES 66, A77-A78",,0,2017
Comparison of Closed-Loop Performance in Individuals with Lower and Higher HbA1c,"L Leelarathna, H Thabit, L Bally, JK Mader, S Hartnell, ME Willinska, ...","DIABETES 66, A272-A273",,0,2017
Methods for reducing false hypoglycemia alarm occurrence,"ES Budiman, GA Hayter, MB Taub, R Hovorka, ME Wilinska, D Dunger","US Patent App. 15/414,550",,0,2017
Integrated closed-loop medication delivery with error model and safety check,"ME Wilinska, ES Budiman, GA Hayter, MB Taub, R Hovorka","US Patent App. 15/193,804",,0,2017
Abstracts from ATTD 2017 10th International Conference on Advanced Technologies & Treatments for Diabetes ,"E Renard, B Bode, G Grunberger, G Steil, W Pories, J Pickup, IB Hirsch, ...","Diabetes Technology & Therapeutics 19 (S1), A-1-A-133",,0,2017
Time to peak Insulin Action Duration influences the glycemic Outcome in Type 1 Diabetes during the Home Phase with Closed Loop Insulin Delivery,"H Kojzar, Y Ruan, H Thabit, L Leelarathna, S Hartnell, ME Willinska, ...","WIENER KLINISCHE WOCHENSCHRIFT 128, S423-S423",,0,2016
The use of closed loop in outpatient/home studies,R Hovorka,"Diabetes Research and Clinical Practice 120, S21",,0,2016
Role of Dual-Hormone Closed-Loop Delivery System in the Future,"L Bally, H Thabit, R Hovorka","Diabetes technology & therapeutics 18 (8), 452-454",,0,2016
Closed-Loop Insulin Delivery in the Intrapartum and Early Postpartum Period in Women with Type 1 Diabetes in Pregnancy,"ZA Stewart, ME Wilinska, S Hartnell, D Simmons, R Temple, K Stanley, ...","DIABETES 65, A353-A353",,0,2016
Insulin Pharmacodynamics and Outcomes during Home Use of Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes,"Y Ruan, H Thabit, L Leelarathna, S Hartnell, ME Wilinska, S Dellweg, ...","DIABETES 65, A255-A255",,0,2016
Overnight closed-loop insulin delivery at home in pregnant women with Type 1 diabetes: a feasibility study: A25 (P444),"Z Stewart, M Wilinska, S Hartnell, D Simmons, R Temple, K Stanley, ...",Diabetic Medicine 33,,0,2016
HIERARCHICAL MODEL OF GLUCOSE-INSULIN REGULATION OVER 12-WEEK HOME USE OF CLOSED-LOOP INSULIN DELIVERY,"Y Ruan, M Wilinska, H Thabit, R Hovorka","DIABETES TECHNOLOGY & THERAPEUTICS 18, A48-A48",,0,2016
HOME USE OF DAY-AND-NIGHT CLOSED-LOOP INSULIN DELIVERY IN ADOLESCENTS WITH TYPE 1 DIABETES: A RANDOMISED CLINICAL TRIAL,"M Tauschmann, JA Allen, ME Wilinska, H Thabit, CL Acerini, DB Dunger, ...","DIABETES TECHNOLOGY & THERAPEUTICS 18, A21-A22",,0,2016
Abstracts from ATTD 2016 9th International Conference on Advanced Technologies & Treatments for Diabetes ,"D Schatz, P Pozzilli, M Sperling, S Del Favero, F Boscari, M Messori, ...","Diabetes Technology & Therapeutics 18 (S1), A-1-A-140",,0,2016
Optimizing Nocturnal Diabetes Control: Optimising Insulin Delivery with New Technology: But Where is the Evidence?,"R Hovorka, H Murphy, Z Stewart, N El Ansari, B Rafiq, S Tsagarakis, ...","HORMONE RESEARCH IN PAEDIATRICS 86, 5-6",,0,2016
NAFLD exacerbates the effect of dietary sugar on liver fat and development of an atherogenic lipoprotein phenotype,"AM Umpleby, F Shojaee-Moradie, B Fielding, X Li, A Marino, N Alsini, ...",Springer,,0,2016
Free-living Home Use of an Artificial Beta Cell in Type 1 Diabetes,"H Thabit, M Tauschmann, JM Allen, L Leelarathna, S Hartnell, ...",Massachusetts Medical Society,,0,2015
Accuracy and Performance of continuous Glucose Monitoring with three Closed-Loop Studies with Home Phase under normal Living Conditions,"H Kojzar, H Thabit, L Leelarathna, ME Wilinska, D Elleri, JM Allen, ...","WIENER KLINISCHE WOCHENSCHRIFT 127, S145-S146",,0,2015
12-week Day-and-Night Closed-Loop Insulin Dose in adult Type-1 Diabetics in Everyday Life: an open multicenter multinational prospective randomized Crossover-Study,"M Holzer, H Thabit, L Leelarathna, S Dellweg, J Mader, S Hartnell, ...","WIENER KLINISCHE WOCHENSCHRIFT 127, S145-S145",,0,2015
Revolutionising type 1 diabetes metabolic control in pregnancy,"H Murphy, Z Stewart, R Hovorka",Society for Endocrinology BES 2015 38,,0,2015
"Evaluation of overnight insulinemia and venous glucose profiles, in closed and open loop system, in children, 6 to 12 years, with type 1 diabetes","U Schierloh, M Wilinska, P Baumann, R Hovorka, T Pieber, C De Beaufort","Pediatric Diabetes 16, 111-112",,0,2015
Twelve-week unsupervised day-and-night closed loop insulin delivery during free daily living in adults with type 1 diabetes: a multicentre randomised cross-over study,"H Thabit, L Leelarathna, S Dellweg, JK Mader, S Hartnell, C Benesch, ...","DIABETOLOGIA 58, S478-S478",,0,2015
"Day and Night Closed Loop Insulin Delivery in Young People with Type 1 Diabetes: A Free-Living, Randomised Clinical Trial","M Tauschmann, JM Allen, ME Wilinska, H Thabit, Z Stewart, P Cheng, ...","DIABETES 64, A58-A58",,0,2015
"Performance of Two Continuous Glucose Measurement Devices, in Closed and Open Loop System, in Pediatric Patients with Type 1 Diabetes","U Schierloh, ME Wilinska, PM Baumann, T Augustin, C De Beaufort, ...","DIABETES 64, A242-A242",,0,2015
MODELLING GLUCOSE KINETICS DURING EUGLYCAEMIC CLAMP FOLLOWING ADMINISTRATION OF RAPID ACTING INSULIN ANALOGUE,"Y Ruan, C Benesch, E Zijlstra, R Hovorka","DIABETES TECHNOLOGY & THERAPEUTICS 17, A162-A162",,0,2015
MODELLING ENDOGENOUS INSULIN CONCENTRATION IN TYPE 2 DIABETES WITH OR WITHOUT CLOSED LOOP INSULIN DELIVERY,"Y Ruan, H Thabit, ME Wilinska, R Hovorka","DIABETES TECHNOLOGY & THERAPEUTICS 17, A43-A45",,0,2015
PERFORMANCE DURING UNSUPERVISED CLOSED LOOP IN CHILDREN AND ADULTS WITH TYPE 1 DIABETES: WHAT MAKES THE DIFFERENCE?,"M Tauschmann, H Thabit, D Elleri, A Lubina-Solomon, M Stadler, ...","DIABETES TECHNOLOGY & THERAPEUTICS 17, A100-A101",,0,2015
"Abstracts from ATTD 2015 8th International Conference on Advanced Technologies & Treatments for Diabetes Paris, France—February 18–21, 2015","Y Reznik, P Pozzilli, W Pories, J Pender, K Spaniolas, D Stefan, ...","Diabetes Technology & Therapeutics 17 (S1), A-1-A-180",,0,2015
Adults with T1DM: Expectations of closed loop technology prior to participation in three month 24 hour ‘free living’trial,"K Barnard, A Young, T Pieber, S Arnolds, H Thabit, R Hovorka","Diabetes Technology & Therapeutics 17 (S1), A108",,0,2015
Day and Night automised Closed-Loop Insulin Treatment for Adults with Type 1 Diabetes: a random Crossover-Study in 3 European Centers,"JK Mader, L Leelarathna, S Dellweg, JM Allen, C Benesch, W Doll, ...","WIENER KLINISCHE WOCHENSCHRIFT 126, S180-S180",,0,2014
Response to Comment on Doyle et al. Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms. Diabetes Care 2014; 37: 1191–1197,"FJ Doyle, LM Huyett, JB Lee, HC Zisser, D Kerr, E Dassau","Diabetes Care 37 (10), e228-e228",,0,2014
Impact of sleep disturbance on daytime function for parents and children with type 1 diabetes,"K Barnard, P Adolfsson, C Hill, D Rankin, R Hovorka, J Lawton",Pediatric Diabetes 15,,0,2014
Factors predictive of overnight closed loop performance during free living in children and adults with type 1 diabetes,"M Tauschmann, H Thabit, L Leelarathna, D Elleri, JM Allen, ...","DIABETOLOGIA 57, S414-S414",,0,2014
Aspart pharmacokinetics in children with type 1 diabetes during closed loop insulin delivery: comparison between diluted (U20) and standard (U100) insulin strengths,"Y Ruan, D Elleri, M Tauschmann, JM Allen, ME Wilinska, DB Dunger, ...","DIABETOLOGIA 57, S393-S393",,0,2014
Accuracy of Continuous Glucose Monitoring (CGM) under free-living conditions during three home closed loop studies,"L Leelarathna, H Thabit, D Elleri, JM Allen, A Lubina-Solomon, JK Mader, ...","DIABETOLOGIA 57, S406-S407",,0,2014
Three to four weeks of overnight closed loop insulin delivery during free living: analysis of randomised crossover studies in adults and adolescents with type 1 diabetes,"H Habit, L Leelarathna, D Elleri, JM Allen, A Lubina-Solomon, M Stadler, ...","DIABETOLOGIA 57, S89-S89",,0,2014
"Four Weeks' Home Use of Overnight Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes: A Multicentre, Randomised, Crossover Study","H Thabit, A Lubina-Solomon, M Stadler, L Leelarathna, E Walkinshaw, ...","Diabetes 63, A61-A61",,0,2014
Factors Affecting the Performance of Day and Night Artificial Pancreas Under Real-World Conditions in Adults with Type 1 Diabetes,"L Leelarathna, S Dellweg, JK Mader, JM Allen, C Benesch, W Doll, ...","DIABETES 63, A241-A241",,0,2014
Overnight Closed-Loop in Young Children with Type 1 Diabetes (T1D) Aged 3 to 6 Years: Comparison between Diluted Insulin vs. Standard Insulin Strength,"D Elleri, JM Allen, M Tauschmann, R El-Khairi, P Benitez-Aguirre, ...","DIABETES 63, A243-A243",,0,2014
Closed loop therapy overnight at home study: psychosocial impact on adolescents with Type 1 diabetes,"J Allen, R Hovorka, D Elleri, H Thabit, L Leelarathna, A Gulati, M Nodale, ...",Diabetic Medicine 31,,0,2014
Psychosocial impact of closed loop therapy for adults with Type 1 diabetes: overnight closed loop at home study: P411Symbol,"H Thabit, R Hovorka, E Walkinshaw, A Lubina-Solomon, M Stadler, ...",Diabetic Medicine 31,,0,2014
Psychosocial impact on parents of adolescents with Type 1 diabetes: overnight closed loop at home study,"D Alleri, R Hovorka, J Allen, H Thabit, L Leelarathna, A Gulati, M Nodale, ...",Diabetic Medicine 31,,0,2014
Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol,"F Shojaee-Moradie, Y Ma, S Lou, R Hovorka, AM Umpleby","Diabetes 63 (2), 815-816",,0,2014
Threshold-based insulin pump-interruption for reduction of hypoglycemia,"P Kardas, P Beck, S Bromuri, F Chiarugi, M Enzmann, B Höll, O Keller, ...","Diabetes Technology & Therapeutics 16 (S1), A-1-A-162",,0,2014
ALTERATION IN GLUCOSE DYNAMICS FOLLOWING WITHDRAWAL OF USUAL THERAPY AND CLOSED-LOOP INSULIN DELIVERY IN INSULIN-NAIVE TYPE 2 DIABETES SUBJECTS,"H Thabit, K Kumareswaran, A Haidar, L Leelarathna, K Caldwell, ...","DIABETES TECHNOLOGY & THERAPEUTICS 16, A24-A24",,0,2014
GLUCOSE CONTROL IN ICU: CGM OR INTERMITTENT BLOOD GLUCOSE MEASUREMENTS,"M Wilinska, R Hovorka","DIABETES TECHNOLOGY & THERAPEUTICS 16, A145-A145",,0,2014
PHARMACOKINETICS OF INSULIN ASPART IN PREGNANT WOMEN WITH TYPE 1 DIABETES: EVERY DAY IS DIFFERENT,"HR Murphy, RJB Goudie, D Lunn, R Hovorka","DIABETES TECHNOLOGY & THERAPEUTICS 16, A91-A91",,0,2014
NO EFFECT OF AGE OF INSULIN CATHETER ON OVERNIGHT CLOSED-LOOP GLUCOSE CONTROL IN HOME SETTINGS,"M Nodale, D Elleri, J Allen, R El-Khairi, H Murphy, ME Wilinska, C Acerini, ...","DIABETES TECHNOLOGY & THERAPEUTICS 16, A42-A43",,0,2014
Clinical review: Consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults,"S Finfer, J Wernerman, JC Preiser, T Cass, T Desaive, R Hovorka, ...","Diabetes technology & therapeutics 16 (SUPPL. 1), S4-S5",,0,2014
Day and Night Home Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes: Three Centre Randomised Crossover Study,"L Leelarathna, S Dellweg, JK Mader, JM Allen, C Benesch, W Doll, ...",American Diabetes Association,,0,2014
Safety and Efficacy of Automated Closed-Loop Glucose Control in the Critical Care Unit,"L Leelarathna, S English, H Thabit, K Caldwell, JM Allen, ...","DIABETES 62, A80-A80",,0,2013
Usability of FlorenceD Closed-Loop System during Overnight Home Use in Adolescents With Type 1 Diabetes,"JM Allen, D Elleri, M Nodale, A Gulati, H Thabit, L Leelarathna, K Caldwell, ...","DIABETES 62, A254-A254",,0,2013
Randomised Controlled Study of 24h Closed-Loop Insulin Delivery in Type 2 Diabetes,"K Kumareswaran, H Thabit, L Leelarathna, K Caldwell, D Elleri, JM Allen, ...","DIABETES 62, A246-A246",,0,2013
Fasting Plasma Glucose Is a Significant Determinant of Initial Insulin Dose in Insulin-Naive Type 2 Diabetes,"H Thabit, K Kumareswaran, L Leelarathna, K Caldwell, D Elleri, JM Allen, ...","DIABETES 62, A655-A655",,0,2013
Comparison of Cambridge closed-loop algorithm (CAM) performance in automated and manual control centres during 23h of day and night closed-loop insulin delivery in a randomised …,"L Leelarathna, A Avogaro, C Benesch, D Bruttomesso, K Caldwell, ...","Diabetic Medicine 30, 74-75",,0,2013
EFFICACY AND SAFETY OF CLOSED-LOOP INSULIN DELIVERY DURING REDUCTION OR OMISSION OF MEAL BOLUSES IN ADOLESCENTS WITH TYPE 1 DIABETES,"D Elleri, JM Allen, G Maltoni, M Nodale, K Kumareswaran, L Leelarathna, ...","DIABETES TECHNOLOGY & THERAPEUTICS 15, A7-A7",,0,2013
CLOSED-LOOP IN ICU: PRECLINICAL IN SILICO STUDIES TO ASSESS SYSTEM LEVEL HAZARDS,"ME Wilinska, R Hovorka","DIABETES TECHNOLOGY & THERAPEUTICS 15, A83-A83",,0,2013
Comparison of two Closed-loop-Algorithm with Open-loop Controls in Patients with Type 1 Diabetes,"JH De Vries, A Avogaro, C Benesch, D Bruttomesso, K Caldwell, ...","WIENER KLINISCHE WOCHENSCHRIFT 124, 21-22",,0,2012
Accuracy and Large Inaccuracy of Two Continuous Glucose Monitoring (CGM) Systems,"L Leelarathna, M Nodale, JM Allen, D Elleri, K Kumareswaran, A Haidar, ...","DIABETES 61, A1-A2",,0,2012
Differenze di genere nella cinetica dei trigliceridi VLDL1 e VLDL2 e degli acidi grassi in uomini obesi e donne obese in post-menopausa,"I Sarac, K Backhouse, F Shojaee-Moradie, M Stolinski, MD Robertson, ...","L'Endocrinologo 5 (13), 233-233",,0,2012
Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: A randomized crossover case series (Diabetes Care (2011) 34 …,"HR Murphy, K Kumareswaran, D Elleri, JM Allen, K Caldwell, M Biagioni, ...","Diabetes Care 35 (1), 191",,0,2012
Update on closed loop systems for the treatment of type 1 diabetes mellitus,R Hovorka,39th Meeting of the British Society for Paediatric Endocrinology and Diabetes 27,,0,2011
Closing the loop-benefits and limitations: INV17,R Hovorka,Pediatric Diabetes 12,,0,2011
Closed-loop glycaemic control over 36 hours in adolescents with type 1 diabetes,"JM Allen, D Elleri, K Kumareswaran, L Leelarathna, M Nodale, K Caldwell, ...","DIABETOLOGIA 54, S395-S395",,0,2011
Podawanie insuliny w modelu zamkniętej pętli w czasie ciąży powikłanej cukrzycą typu 1,"HR Murphy, D Elleri, JM Allen, J Harris, D Simmons, G Rayman, ...","Diabetes Care 8 (1), 13-12",,0,2011
GLP-1 Enhances Insulin Biosynthesis in Type 2 Diabetic Subjects during Hyperglycemia,"Z Chen, H Jayatillake, G Cruikshank, BN Zheng, R Hovorka, E Rogatsky, ...","DIABETES 60, A94-A94",,0,2011
Technological advances in pregnancy complicated by type 1 diabetes,"HR Murphy, D Elleri, K Kumareswaran, R Hovorka","Practical Diabetes International 28 (3), 104-105a",,0,2011
A meta-analysis of cytokines in Major Depression,"E Abbink, E Engwerda, C Tack, B de Galan, SA Amiel, T Danne, ...","Diabetes Technology & Therapeutics 13 (2), 173-293",,0,2011
Space GlucoseControl with the incorporated enhanced model predictive control algorithm is a safe and reliable tool for glycaemic control in medical ICU patients,"K Amrein, M Ellmerer, R Hovorka, KH Smolle, N Kachel, TR Pieber, ...","Critical Care 15 (1), P401",,0,2011
Which roadblocks need to be removed on the way to the closed loop?: INV15,R Hovorka,Pediatric Diabetes 11,,0,2010
Automated overnight closed-loop glucose control in young children with type 1 diabetes (T1D): P/178/WED,"J Allen, D Elleri, M Nodale, M Wilinska, J Mangat, AM Larsen, C Acerini, ...","Pediatric Diabetes 11, 101-102",,0,2010
Overnight closed-loop glucose control following consumption of alcohol in adults with type 1 diabetes,"K Kumareswaran, J Harris, D Elleri, JM Allen, M Nodale, ME Wilinska, ...","DIABETOLOGIA 53, S25-S26",,0,2010
Reducing risk and severity of hypoglycemia with closed loop insulin delivery in type 1 diabetes: from dream to reality,R Hovorka,"Diabetic Hypoglycemia 3 (1), 3-7",,0,2010
Absorption of an Evening Meal with Complex Carbohydrates (CHO) in Type 1 Diabetes (T1D),"D Elleri, J Harris, K Kumareswaran, J Allen, M Nodale, A Swamy, ...","DIABETES 59, A422-A422",,0,2010
Closed Loop Glucose Control Overnight and after High Carbohydrate Meals during Pregnancy,"HR Murphy, D Elleri, J Allen, J Harris, D Simmons, G Rayman, R Temple, ...","DIABETES 59, A506-A506",,0,2010
The artificial pancreas: hype or hope?,R Hovorka,"Diabetes and Primary Care 12 (3), 136-137",,0,2010
Overnight closed-loop insulin delivery in adults with Type 1 diabetes: P119,"K Kumareswaran, J Harris, J Allen, D Elleri, M Nodale, J Hayes, ...",Diabetic Medicine 27,,0,2010
Dalla Letteratura,"R Hovorka, JM Allen, D Elleri, LJ Chassin, J Harris, D Xing, C Kollman, ...","Lancet 375 (9713), 481-9",,0,2010
Afternoon exercise and overnight closed-loop (cl) insulin delivery in adolescents with type 1 diabetes (t1d): O/3/WED/08,"D Elleri, C Acerini, J Allen, L Chassin, U Ekelund, A Larsen, M Nodale, ...","Pediatric Diabetes 10, 20-21",,0,2009
Safety of overnight closed-loop using FreeStyle Navigator continuous glucose monitoring system (FSN) and model predictive control (MPC) algorithm: in silico assessment,"ME Wilinska, ES Budiman, JA Allen, D Elleri, CL Acerini, GA Hayter, ...","DIABETOLOGIA 52, S365-S366",,0,2009
ENHANCED MODEL PREDICTIVE CONTROL (EMPC) ALGORITHM IS A SAFE AND RELIABLE TOOL FOR THE ESTABLISHMENT OF GLYCAEMIC CONTROL IN SERIOUSLY ILL MEDICAL ICU PATIENTS-RESULTS OF ALDEA 01,"K Amrein, M Ellmerer, R Hovorka, KH Smolle, N Kachel, D Parcz, ...","INTENSIVE CARE MEDICINE 35, 120-120",,0,2009
Artificial Pancreas Systems: Overnight Closed-Loop Insulin Delivery with Model Predictive Control: Assessment of Hypoglycemia and Hyperglycemia Risk Using Simulation Studies,"ME Wilinska, ES Budiman, MB Taub, D Elleri, JM Allen, CL Acerini, ...","Journal of diabetes science and technology (Online) 3 (5), 1109",,0,2009
Evidence for Multiple Pools and Preferential Secretion of Newly Synthesized Insulin In Vivo,"A Sihleanu, A Williams, BN Zhang, K Bratten, G Cruikshank, H Jayatillake, ...","DIABETES 58, A59-A59",,0,2009
Overnight closed-loop (CL) glucose control in children and adolescents with type 1 diabetes (T1D): towards home testing,"D Elleri, CL Acerini, JM Allen, LJ Chassin, C Kollman, J Harris, T Hovorka, ...","HORMONE RESEARCH 72, 32-32",,0,2009
P009 CONTINUOUS GLUCOSE SENSOR COMBINED WITH COMPUTER ALGORITHM FOR TIGHT GLUCOSE CONTROL IN CARDIAC SURGERY PATIENTS,"J Kremen, M Mraz, J Blaha, P Kopecky, R Hovorka, E Kotrlikova, ...","Clinical Nutrition Supplements 2 (4), 28-29",,0,2009
Technology for Hospital Management of Diabetes: Evaluation of Implementation of a Fully Automated Algorithm (Enhanced Model Predictive Control) in an Interacting Infusion Pump …,"R Kulnik, J Plank, C Pachler, ME Wilinska, A Groselj-Strele, D Röthlein, ...","Journal of diabetes science and technology (Online) 2 (6), 963",,0,2008
Glucose model at ICU,"R Hovorka, LJ Chassin, M Ellmerer, J Plank, ME Wilinska","Physiological Measurement 29, 959-978",,0,2008
Translating continuous glucose monitoring systems: toys or tools.,C De Block,"Current diabetes reviews 4 (3), 157",,0,2008
Glucose and GLP-1 stimulate insulin biosynthesis in human subjects in vivo,"DT Stein, V Tomuta, S Sharma, H Jayatillake, S Schlanger, R Hovorka, ...","DIABETES 57, A63-A63",,0,2008
Insulin and rate of glucose absorption in type 1 diabetes,"ME Pennant, LJ Bluck, L Marco-Vecchio, B Salgin, R Hovorka, DB Dunger","DIABETES 57, A356-A356",,0,2008
Evaluation of the implementation of a fully automated algorithm (eMPC) in an interacting infusion pump system for the establishment of tight glycaemic control in medical ICU …,"J Plank, R Kulnik, C Pachler, R Hovorka, D Röthlein, N Kachel, M Wufka, ...","Critical Care 12 (2), P156",,0,2008
Measurement of postprandial triacylglycerol kinetics in both endogenous and exogenous lipoproteins using a novel immunoaffinity chromatography method,"F Sun, M Stolinski, F Shojaee-Moradie, R Hovorka, AM Umpleby","DIABETOLOGIA 51, S300-S300",,0,2008
Randomized Controlled Trial to Evaluate Blood Glucose Control by the Model Predictive Control Algorithm with Variable Sampling Rate (eMPC) vs. Routine Glucose Management …,"M Haluzik, J Kremen, J Blaha, M Matias, P Kopecky, J Rulisek, ...",Diabetes 56,,0,2007
Evaluation of a Model Predictive Control Algorithm Using Time Variant Sampling to Establish Tight Glycemic Control for Intensive Care Patients.,"C Pachler, J Plank, H Weinhandl, R Hovorka, L Chassin, P Kaufmann, ...",Diabetes 56,,0,2007
Computer-advised insulin infusion in critically ill patients–a randomized controlled trial,"J Cordingley, N Dormand, S Squire, M Wilinska, L Chassin, R Hovorka, ...","Critical Care 11 (2), P137",,0,2007
Closed loop systems: S20,R Hovorka,"Pediatric Diabetes 7, 10-11",,0,2006
Computer-advised insulin infusion in postoperative cardiac surgery patients: a randomized prospective controlled multicenter trial,"J Cordingley, J Plank, J Blaha, M Wilinska, L Chassin, C Morgan, ...","Critical Care 10 (1), P3",,0,2006
Computational model of cellular metabolic dynamics: effect of insulin on glucose disposal in human skeletal muscle.,"PT Rao, KS Rao, CL Usha, A Makroglou, J Li, Y Kuang, DA Cavan, ...","Asian Journal of Mathematics & Statistics 4 (1), 559-573",,0,2006
Randomized Controlled Study for the Evaluation of Automated Blood Glucose Control in Critically Ill Patients,"M Ellmerer, J Plank, W Toller, B Rigler","Diabetes 54, A104",,0,2005
"Partitioning glucose distribution/transport, disposal","RH Jones, IJ Gowrie, NC Jackson, RS Tudor, AM Umpleby, R Hovorka, ...","Am J Physiol Endocrinol Metab 288 (5), E1038-E1046",,0,2005
Evaluation of Bayesian hierarchical and nonlinear regression estimation of insulin sensitivity by the minimal model in 560 men without diabetes,"O Agbaje, R Hovorka, I Godsland",Diabetic Medicine Supplement 21,,0,2004
Insulin sensitivity and secretion in the first two years of Type 2 diabetes.,"OF Agbaje, SD Luzio, R Hovorka, DR Owens","DIABETOLOGIA 46, A151-A151",,0,2003
Other Original Articles-Associations of Glucose Control with Insulin Sensitivity and Pancreatic b-Cell Responsiveness in Newly Presenting Type 2 Diabetes,"AI Albarrak, SD Luzio, LJ Chassin, RA Playle, DR Owens, R Hovorka","Journal of Clinical Endocrinology and Metabolism 87 (1), 198-203",,0,2002
Effects of intravenous infusion of apolipoprotein AI/phosphatidylcholine discs in a subject with familial lecithin: cholesterol acyltransferase deficieny: Clues to LCAT function,"N Nanjee, CJ Cooke, FJ Semeria, R Hovorka, ER Carson, NE Miller","CIRCULATION 104 (17), 178-178",,0,2001
Reproducibility of pancreatic beta-cell responsiveness during MTT and OGTT in healthy subjects,"AIS Albarrak, SD Luzio, R Playle, R Hovorka, DR Owens","DIABETOLOGIA 44, A137-A137",,0,2001
Insulin sensitivity of glucose transport and glucose disposal during IVGTT,"R Hovorka, PV Carroll, M Umpleby, L Chassin, NC Jackson, RS Tudor, ...","Diabetes Research and Clinical Practice 50, 163",,0,2000
Causal probabilistic networks for solving parameters in compartmental models,"D Southerden, R Hovorka","IFAC Proceedings Volumes 32 (2), 5656-5661",,0,1999
Low insulin effectiveness in poorly controlled type 1 diabetes: an overlooked therapeutic target?,"BC Turner, E Jenkins, OK Hejlesen, S Andreassen, R Hovorka, D Kerr, ...","Proceedings of 35th Annual Meeting of the Easd, 28 September-2 October 1999 …",,0,1999
How can we measure insulin sensitivity?,R Hovorka,,,0,1999
DIAS-NIDDM,"RS Tudor, R Hovorka, DA Cavan, D Meeking, OK Hejlesen, ...",Computer Methods and Programs in Biomedicine,,0,1998
"Titus Schleyer"", Heiko Spallek"", Maziar Arsalan","S Svačina, T Haas, R Hovorka","MEDINFO 98: Proceedings of the 9th World Congress on Medical Informatics, 180",,0,1998
Hepatocyte-stimulated expression of hepatocyte growth factor (HGF) in cultured rat hepatic stellate cells,"JO Jansson, S Skrtic, V Wallenius, S Ekberg, A Brenzei, AM Gressner","Growth Hormone & IGF Research 4 (8), 315-316",,0,1998
RHIGF-I administration increases in vivo peripheral insulin sensitivity in adults with type 1 diabetes mellitus,"PV Carroll, ER Christ, I Gowrie, R Hovorka, DL Russell-Jones, ...","Growth Hormone & IGF Research 4 (8), 315",,0,1998
A pilot study of the 32 hour hormonal response to spontaneous nocturnal hypoglycaemia in Type 1 diabetic patients,"KD Jensen, OK Hejlesen, HH Lervang, S Andreassen, PE Jacobsen, ...",Medical and Scientific Section Spring Meeting of the British Diabetic …,,0,1998
"Static, dynamic information and modelling in metabolic medicine","S Svaeina, T Haas, R Hovorka","STUDIES IN HEALTH TECHNOLOGY AND INFORMATICS, 180-180",,0,1998
Static and dynamic information in metabolic medicine.,"S Svacina, T Haas, R Hovorka","Sbornik lekarsky 99 (4), 579-582",,0,1998
DIAS-the Diabetes Advisory System,"OK Hejlesen, S Andreassen, R Hovorka, DA Cavan",Computer Methods and Programs in Biomedicine,,0,1997
Acid-based chemistry of the blood,"SE Rees, S Andreassen, R Hovorka, R Summers, ER Carson",Computer Methods and Programs in Biomedicine,,0,1996
A Comparison of Six Deconvolution Techniques,"R Hovorka, RA Bates",Journal of Pharmacokinetics and Biopharmaceutics 24 (3),,0,1996
"Interdisciplinary application of nonlinear time series methods, physics reports.","AK El-Jabali, S Andreassen, JJ Benn, R Hovorka, KG Olesen, ER Carson, ...","Journal of Applied Sciences 3 (4), 153-165",,0,1994
A probabilistic model for prediction of blood glucose and advice on insulin dose,"JJ Benn, R Hovorka, O Rasmussen, KG Olesen, ER Carson, ...",International Symposium of the European Association for the Study of Diabetes,,0,1991
Consultation System for Insulin Dosage Adjustment,"R Hovorka, S Svacina, ER Carson","Medical Informatics Europe 1991, 1044-1044",,0,1991
A Consultation System to Assist in Insulin Therapy for In-Patients,"R Hovorka, S Svacina, ER Carson, CD Williams","Clinical Science 78 (s22), 14P-14P",,0,1990
Consultation system for insulinotherapy of diabetes mellitus [Abstract of thesis],R Hovorka,"Commentationes Mathematicae Universitatis Carolinae 31 (1), 193-194",,0,1990
Acylpyrin and glucose homeostasis in diabetes mellitus,"J Skrha, S Svacina, J Hilgertová, J Srámková, R Hovorka, J Perusicová, ...","Casopis lekaru ceskych 127 (5), 144",,0,1988
Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.,"NF Mohd Yusof, A Md. Som, AS Ibrehem, SA Ali, RN Bergman, LS Phillips, ...","Journal of Applied Sciences 14 (13), 1456-1467",,0,1981
Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance w ith enhanced calibrations.,"L Leelarathna, SW English, H Thabit, K Caldwell, JM Allen, ...",,,0,0
"Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Rea l Life Settings: Longitudinal Qualitative Study.","J Lawton, M Blackburn, D Rankin, JM Allen, FM Campbell, L Leelarathna, ...",,,0,0
DATE DAY TIME,"S Groth, A Coward, R Hovorka, C Yajnik, ADT Forrester, G Ma, T Forrester, ...",CO-ORDINATED RESEARCH PROJECT ON APPLICATION OF NUCLEAR TECHNIQUES IN THE …,,0,0
The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference ,"C Bailey, T Heise, J Castle, R Beck, I Hirsch, M Gillon-Keren, E Renard, ...","Diabetes Technology & Therapeutics 21 (S1), A-1-A-164",,0,0
Closed-loop insulin therapy for outpatients with type 1 diabetes: a systematic review and meta-analysis,R Hovorka,,,0,0
Original Research Clinical Care/Education/Nutrition/Psychosocial,"J Blaha, P Kopecky, M Matias, R Hovorka, J Kunstyr, T Kotulak, M Lips, ...",,,0,0
Closed-Loop Insulin Delivery in Adults with Well-Controlled Type 1 Diabetes: A Free-Living Day-and-Night Randomised Crossover Study,"L Bally, H Thabit, H Kojzar, JK Mader, J Qerimi-Hyseni, S Hartnell, ...","Age (years) 41, 13",,0,0
Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with type 2 diabetes,"AL Brackenridge, N Jackson, W Jefferson, M Stolinski, F Shojaee-Moradie, ...",,,0,0
"Our thanks to those who have helped with this issue of Expert Review of Medical Devices. Listed below are the authors, referees and others who have kindly given their time …","G Ailawadi, N Al-Attar, M Arsalan, M Barten, H Bittner, S Bleiziffer, ...",,,0,0
Léèba hyperglykemie u kriticky nemocných pacientù: srovnání standardního protokolu a poèítaèového algoritmu,"J Křemen, J Bláha, P Kopecký, L Bošanská, E Kotrlíková, T Roubíček, ...",,,0,0
Mass kinetics of apolipoprotein AI in interstitial fluid after intravenous apolipoprotein AI/lecithin discs in humans,"R Hovorka, MN Nanjee, CJ Cooke, IP Miller, WL Olszewski, NE Miller, ...",,,0,0
Academic qualifications,R Hovorka,,,0,0
